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AA = arachidonic acid 
ALA = α-linolenic acid 
AFM = atomic force microscopy 
LA = linoleic acid 
Cer = ceramides  
Chol = cholesterol 
CLA = conjugated linoleic acid 
COX = ciclooxygenase 
DAG = diacylglycerol  
DHA = docosahesaenoic acid 
DGLA = dihomo-gamma-linolenic acid 
DPA = docosapentaenoic acid 
DRM = detergent-resistant membrane 
DSC = differential scanning calorimetry 
EFA = essential fatty acids 
EGFR = epidermal growth factor receptor 
Elov = elongase 
EM = electron microscopy 
EPA = eicosapentaenoic acid 
ESR = electron spin resonance  
FA = fatty acid 
FASN = fatty acid synthase  
FBS = fetal bovine serum  
FCS = fluorescence correlation spectroscopy 
FM = fluorescence microscopy  
FRET = fluorescence resonance energy transfer 
GC = gas chromatography  
GLA = gamma linolenic acid 
GPI = glycosylphosphatidylinositol-linked proteins 
GPLs = glycerophospholipids  
GPMVs = giant plasma membrane vesicles  
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PGs = prostaglandins 
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PLCγ = phospholipase Cγ  
PS = phosphatidylserine 
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SEM = scanning electron microscopy  
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SPM = scanning probe microscopy 
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Summary 
 
Today, the Western diet is substantially enriched in n-6 PUFAs 
(shifting the balance from the optimal n-6:n-3 ratio of 1–5:1 to 
approximately 20:1) due to the increased consumption of food items rich 
in n-6 and simultaneous reduction of fish intake. Diet enriched in n-6 
PUFAs determines an unbalance between bioactive lipid mediators that 
are involved in regulating inflammation. These bioactive products can 
contribute to the development of numerous chronic diseases, including 
cancer. Many studies have demonstrated that genetic factors contribute 
only for 5% to the onset of cancer, while 95% is due to environmental 
conditions factors, including lifestyle-related factors (tobacco, alcohol 
and physical activity), external stimuli (radiation and infections) and diet 
that represents about 30–35% of the risk factors. 
There are in vitro and in vivo evidences that the DHA and EPA 
administration is able to reduce cancer proliferation increase apoptosis  
as well as inhibit angiogenesis and metastasis, and to influence cancer 
differentiation. Several molecular mechanisms have been proposed for 
the anticancer activity of n-3 PUFAs, including inhibition of cell 
proliferation, anti-angiogenic action and enhancement of apoptosis. The 
multiple actions of n-3 PUFAs appear to involve multiple mechanisms 
that connect the cell membrane, the cytosol, and the nucleus. N-3 PUFAs 
may act also modulating cell membrane FA composition.  
 
 
 
Summary 
 
 
The plasma membrane is involved in many aspects of cell 
biology, including proliferation, differentiation and apoptosis. 
Phospholipids (PLs) fatty acid composition within cell membrane play a 
key role in maintaining its fluidity, structure and function. Thus, changes 
in membrane PLs fatty acid composition can influence the function of 
cells. In particular, n-3 PUFAs incorporated into membrane PLs can 
potentially affect a variety of plasma membrane physical properties 
including membrane thickness, fluidity and elasticity, structure and 
function in particular of membrane microdomains (lipid rafts); 
moreovere they can cause alteration of cell signaling pathways that lead 
to altered transcription factor activity and changes in gene expression. 
We have observed that DHA is incorporated in breast cancer cell 
membrane with different specificity for the PLs moiety. Moreover, we 
have demonstrated that the treatment with DHA determines a reduction 
of cell proliferation, inhibition of EGFR activity and induction of 
apoptotic process, suggesting that these effects might be the 
consequences of cell membrane alterations induced by FAs. 
The main purpose of my research project was to analyze the 
effects of PUFA administration on membrane microdomain structure and 
function in breast cancer cells by a combination of biophysical and 
biochemical techniques. In my study I have used Atomic Force 
Microscopy (AFM) to perform a morpho-dimensional characterization 
of lipid rafts as Detergent-Resistant Membrane (DRM) isolated from 
MDA-MB-231 breast cells (estrogen receptor negative and over-
expressing Epidermal growth factor receptor (EGFR)).  
 
 
Summary 
 
 
AFM providing nanometer spatial resolution and operating in 
physiological-like conditions without fixation, staining, or labeling, 
appears to be a useful tool to visualize and quantitatively characterize the 
topology of biological membranes as well as of their protein content. 
AFM imaging of DRM fractions showed membrane patches 
whose height corresponds to the one awaited for a single lipid bilayer as 
well as the presence of microdomains with lateral dimensions in the 
order of a few hundreds of nanometers. Moreover, AFM-
immunolabeling using specific antibodies suggested the presence, in 
these microdomains, of a characteristic marker of lipid rafts, the protein 
flotillin-1. In addition, my results suggested that AFM could be an useful 
tool to study the phase coexistence of a Liquid-disordered (Ld) and 
Liquid-ordered (Lo) domain in purified  membrane microdomains.  
Finally, I have investigated the role of lipid changes induced by 
DHA in membrane microdomain structure and function by biochemical 
tecniques. The data showed that the incubation with DHA determines its 
incorporation in all PLs, with different specificity for PI, PS and PC, and 
a reduction of sphingomyelin (SM) and cholesterol (Chol) content in 
membrane microdomains. Moreover, I have demonstrated that DHA can 
exclude key proteins, such as EGFR and Ras, from membrane 
microdomains, modifying their downstream signaling, such as Erk1/2 
and Akt.  
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1.1 N-6 and n-3 fatty acids: structure and metabolism 
 
From a chemical point of view, fatty acids (FAs) are carboxylic 
acids characterized by a long hydrocarbon chain with a carboxyl group 
at one end and a methyl group at the other. Fatty acids (FAs) differ in the 
length of the carbon chain: short-chain FAs have less than 8 carbons, 
whereas long-chain FAs have 16 or more carbons. The number and the 
type of bonds (single or double) between the carbons define the different 
kind of fatty acids. In particular, FAs without double bonds are known as 
saturated, while FAs with double bonds are known as unsaturated. 
Unsaturated fatty acids include Monounsaturated Fatty Acids (MUFAs) 
and Polyunsaturated Fatty Acids (PUFAs).  
PUFAs are grouped into two main families. ω-6 (or n-6) and ω-3 
(or n-3), distinguished by a position of the first double bond closest to 
the methyl end. Linoleic acid (LA, C18:2n-6) and α-linolenic acid (ALA, 
C18:3n-3) with 18 carbon atoms in acyl chain and two (LA) or three 
(ALA) double bonds, are the precursors of n-6 and n-3 PUFAs, 
respectively. From a nutritional point of view, LA and ALA are 
identified as ‘‘Essential’’ fatty acids (EFA), because in mammalians, 
including humans, they cannot be synthesized de novo due to the 
absence of ∆12- and ∆15-desaturases, and therefore they must be 
obtained from the diet.  
For example, vegetable oils such as soybean, corn, sunflower, 
safflower and cotton seed oils are enriched to n-6 FAs, while linseed and 
canola oils are rich in n-3 FAs [1].  
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Normally, in healthy subjects, most of part of LA and ALA 
assimilated by dietary are used to produce energy [2], and approximately 
only 3.0% and 1.5% of them are metabolized into longer PUFAs to 
satisfy the metabolic need. Starting from LA and ALA, using enzyme 
system, it is possible to produce longer and more unsaturated PUFAs by 
the same microsomal [3]. In particular, LA is converted into Arachidonic 
acid (AA, C20:4n-6), and ALA is converted first into Eicosapentanoic 
acid (EPA, C20:5n-3) and, subsequently, into Docosahexanoic acid 
(DHA, C22:6n-3) the longest and the most unsaturated fatty acid 
(Figure 1.1). 
 
 
 
Figure 1.1. Polyunsaturated fatty acids (PUFAs) structures (from Raposo et al.,2013 
[4]). 
A) Eicosapentaenoic acid (EPA), B) Docosahexaenoic acid (DHA), and C) Arachidonic 
acid (AA). 
 
The human body converts LA and ALA into these higher 
unsaturated derivatives by a series of desaturation and elongation steps. 
As shown in Figure 1.2, the Δ6-desaturase recognizes and converts LA 
and ALA into γ-linolenic acid (GLA, C18:3n-6), and octadecatetraenoic 
(stearidonic, C18:4n-3) acids, respectively.  
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This step is followed by a cycle of elongation via elongase (Elov-
l) and desaturation by ∆5-desaturase to generate AA and EPA. AA is 
either metabolized to tetracosapentaenoic acid (C24:5n-6) by two cycles 
of elongations and one of desaturation by ∆6-desaturase, and eventually 
β-oxidized to docosapentaenoic acid (DPA, C22:5n6). EPA is either 
metabolized to DHA, this conversion involves the addition of two 
carbons by two consecutive elongase Elovl-5 and 2 to produce 
tetracosapentaenoic acid (C24:5n-3) and a desaturation using Δ6-
desaturase to produce tetracosa-hexaenoic acid (C24:6n-3). Finally, 
tetracosapentaenoic acid (C24:5n-6) and tetracosahexaenoic acid 
(C24:6n-3) are translocated from the endoplasmic reticulum (ER) to the 
peroxisomes, where the β-oxidation pathway involves acyl chain 
shortening of C2 to produce DPA and DHA, and then back to 
endoplasmic reticulum (ER) [5].  
Since biosynthesis of FAs and phospholipids (PLs) occurs in ER, 
the intermediates of the PUFA metabolism can either be incorporated 
into PLs, or become the substrate for further elongation/desaturation 
reactions. 
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Figure 1.2. PUFA metabolic pathways (from Poudyal et al., 2011[6]). 
PGs prostaglandins; PGI prostacyclins; LT leukotriene; TX thromboxane.  
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1.2 Health benefits of n-3 PUFAs 
 
Today, the Western diet is substantially enriched in n-6 PUFAs 
(shifting the balance from the optimal n-6:n-3 ratio of 1–5:1 to 
approximately 20:1) [7,8] due to the increased consumption of food 
items rich in n-6 and simultaneous reduction of fish intake. Diet enriched 
of n-6 PUFAs determines an unbalance between bioactive lipid 
mediators that are involved in regulating inflammation. These bioactive 
products can contribute to the development of numerous chronic 
diseases, including cardiovascular and inflammatory disorders. On the 
other hand, n-3 PUFAs are very important fatty acids in human nutrition, 
indeed, they have a wide range of physiological functions in the human 
body. As components of structural PLs in the cell membrane, they 
modulate cellular signalling, cellular interaction, and membrane fluidity 
[9]. The potential health benefits of n-3 PUFAs, DHA and EPA in 
particular, have been the focus of many researches since 1980, when 
epidemiologic data showed that populations consuming large quantities 
of fish (e.g. salmon, tuna, mackerel, and sardines) had lower rates of 
inflammation [10,11]. In the past decade, a lot of studies have shown the 
benefits of dietary consumption of n-3 PUFAs in cardiovascular disease 
[12-15], atherosclerosis [16], diabetes [17], metabolic syndrome [6], 
neurological/neuropsychiatric disorders [18,19], osteoporosis [20,21], 
pregnancy [23,23] and autoimmune diseases [24,25].  
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The protective effects of n-3 PUFAs are particularly convincing 
for cardiovascular diseases (CVD). The first observation dates back 
almost 50 years, when Dyerberg and coworkers observed the low 
incidence of mortality rate from coronary heart disease in Greenland 
Eskimos (a population consuming a diet enriched in n-3 PUFAs) [26,27]. 
In the past years, the most compelling evidence for the cardiovascular 
benefit obtained by n−3 PUFAs, derives from an analysis of pooled data 
from 3 controlled trials of 32,000 participants. These trials showed 
reductions in cardiovascular events of 19% to 45% [28]. Among the 
possible mechanisms that may contribute to the cardiovascular benefits 
of n-3 PUFAs, there are their ability to lowering of plasma triglycerides 
[29], decreasing blood pressure [30] and improving vasodilatation [31]. 
Other mechanisms include the generation of less-potent inflammatory 
mediators (e.g. 3-series prostanoids and 5-series leukotrienes) that 
compete for AA metabolism and pro-inflammatory effects of AA 
derived eicosanoids [32]. N-6 and n-3 PUFAs are substrates for the 
production of various eicosanoids and docosanoids. The mono-
hydroxylated PUFA metabolites of AA, 15- hydroxyeicosatetraenoic 
acid (15-HETE) and 5- hydroxyeicosatetraenoic acid (5-HETE) are 
direct precursors for Lipoxins (LXA4 and LXB4), which, in contrast to 
Prostaglandins (PGs) and Leukotrienes (LTs), attenuate the 
inflammatory effect. Moreover, current evidence indicates that n-3 
PUFAs are precursors of a distinct set of lipid mediators. The novel n-3 
PUFA-pro-resolution lipid mediators like Resolvins (Rv), Protectins 
(PD) and Maresins (MaR) are responsible for the active resolution of 
inflammation [33-35].  
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EPA and DHA are substrates for various classes of Rv of the E 
(originating from EPA) and D (originating from DHA) series, 
respectively (Figure 1.3).  
 
 
 
Figure 1.3. New families of PUFA-derived lipid mediators (from Serhan & Chiang 
2008 [35]). 
These mediators include n-6 (AA)-derived Lipoxins (LXs) and aspirin-triggered LXs 
(ATL); n-3 (EPA)-derived Resolvin E-series (RvEs); (DHA)-derived Resolvin D-series 
(RvDs) and Protectins (PDs). 
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1.3 N-3 PUFA, diet and cancer 
 
Many studies have demonstrated that genetic factors contribute 
only for 5% to the onset of cancer, while 95% is due to environmental 
conditions factors, including lifestyle-related factors (tobacco, alcohol 
and physical activity), external stimuli (radiation and infections) and diet 
that represents about 30–35% of the risk factors [36]. Indeed, for the past 
few decades, epidemiologic studies have suggested a relationship 
between dietary lipids and development/progression of cancer [37]. 
Specific dietary fatty acids, such as n-3 PUFAs, have been suggested to 
play a key role. In fact, PUFAs are important for the normal 
development and function of the organism, and are essential in 
maintaining human health. There are in vitro and in vivo evidences that 
the DHA and EPA administration is able to reduce cancer proliferation 
and to increase apoptosis [38,39] as well as inhibit angiogenesis and 
metastasis, and to influence cancer differentiation [40,41].  
This is a result of various pathways including, for example, 
inhibition of AA metabolism and independent effects on various 
cytokines involved in tumourigenesis. These data suggest that PUFAs 
can show a potential antitumor activity representing an effective 
adjuvant in cancer chemotherapy, and improve a few of the secondary 
complications associated with cancer, like cachexia [42]. Moreover, the 
efficacy of various cancer chemotherapy drugs, such as doxorubin, 
[43,44], tamoxifen [45], and mitomycin C [46], and of radiation therapy 
[47] has been increased, when the n-3 PUFAs were included in the diet 
of rodents or in cell culture medium. Several molecular mechanisms 
have been proposed for the anticancer activity of n-3 PUFAs, including 
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inhibition of cell proliferation, enhancement of apoptosis and anti-
angiogenic action [38,48].  
Moreover, new mechanisms are frequently reported as we gain 
additional knowledge of the regulation of gene expression by FAs. For 
these reasons, it is likely that suppression of tumor cell growth is related 
to the combination of different mechanisms instead than a single, unique 
activity that is the main mechanism of action.  
 
1.4 Mechanisms of Action of n-3 PUFAs in cancer 
 
The multiple actions of n-3 PUFAs appear to involve multiple 
mechanisms that connect the cell membrane, the cytosol, and the 
nucleus. For some actions, n-3 PUFAs appear to act via receptors or 
sensors, so regulating signaling processes that influence patterns of gene 
expression. Moreover, n-3 PUFAs seem to involve changes in cell 
membrane FA composition. Changing membrane composition can in 
turn affect membrane order, lipid rafts formation, intracellular signaling 
processes, gene expression, and the production of both lipid and peptide 
mediators [49]. 
Some of the mechanisms proposed for the action of n-3 PUFAs include: 
 suppression of AA-derived eicosanoid biosynthesis; 
 influences on transcription factor activity and gene expression; 
 alteration of estrogen metabolism; 
 increased or decreased production of free radicals and reactive 
oxygen species;  
 mechanisms involving alterations of cell membrane fluidity and 
structure. 
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Inhibition of AA– derived eicosanoid biosynthesis 
 
The eicosanoids are short-lived, hormone-like bioactive lipid 
mediators with chain lengths of 20 carbons associated with 
inflammation. They include different classes of substances: 
Prostaglandins (PGs), Prostacyclins, Thromboxanes (TXs) and 
Leukotrienes (LTs).  AA, EPA and DHA are the endogenous precursors 
for the biosynthesis of eicosanoids. The synthesis of eicosanoids begins 
with the release of PUFAs from the sn-2 position of membrane 
phospholipids by the action of the enzyme phospholipase A2. Thereafter, 
these PUFAs are metabolized by two major enzyme pathways: 
Cyclooxygenases (COX), Lipoxygenases (LOX) or cytochrome P450 
monooxygenases. The COX give rise to prostaglandins and 
thromboxanes, whereas the LOX produce LTs and lipoxins. The relative 
proportions of PUFAs in cell membranes are the primary factors in 
regulating of eicosanoid that will be generated. Because the major PUFA 
in cell membranes is AA, most eicosanoids produced will be of the 2-
series prostanoids (PGs and TXs) and of the 4-series leukotrienes. AA-
derived eicosanoids, such as prostaglandin E2 (PGE2), leukotriene B4 
and thromboxane A2, have promoting effects in cancer cell growth, 
angiogenesis, and invasion [50]. For example, PGE2 promotes tumor 
cell survival by inhibition of apoptosis and stimulation of cell 
proliferation. If n-3 PUFAs are included in the diet and are incorporated 
into cell membranes, they can inhibit the biosynthesis of AA-derived 
eicosanoids. This effect is achieved at several levels. N-3 PUFAs can 
partially replace AA into membrane phospholipids, thereby decreasing 
the availability of AA precursors and favoring the biosynthesis of EPA-
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derived eicosanoids. Moreover, they can suppress COX-2 and compete 
with n-6 PUFAs for COX to form eicosanoids. N-3 PUFAs compete 
with n-6 PUFAs for desaturases and elongases, and n-3 PUFAs have 
greater affinities for the enzymes than  n-6 PUFAs. Thus, a higher intake 
of n-3 PUFAs reduces the desaturation and elongation of LA to AA and 
thus the production of AA-derived eicosanoids [51]. Finally, as 
discussed above EPA and DHA can also be metabolized to resolvins and 
protectins.  
These compounds possess immune-regulatory actions and it is 
well documented that inflammation plays an important role in the 
development of numerous human malignancies, including cancer. Thus 
one other possible mechanism for inhibition of tumor growth by n-3 
PUFAs is the resolution of inflammation process through production of 
these immune-regulatory compounds.  
 
Influence on transcription factor activity and gene expression 
 
PUFAs and their metabolites can modulate gene expression 
acting as ligand to nuclear receptors such as Peroxisome Proliferator-
Activated Receptors (PPARs) and Nuclear transcription Factor κB (NF-
κB). 
 
Peroxisome Proliferator-Activated Receptor 
PPARs are nuclear hormone receptors, and are composed of three 
isotypes: PPARα, PPARγ, and PPARδ. During recent years, the 
intensive study of PPARs has revealed their importance in both normal 
physiology and in the pathology of various tissues.  
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PPARs play an important role in the gene regulation involved in 
lipid metabolism including fatty acid transport and mitochondrial 
oxidation, inflammation and the development of atherosclerosis or 
diabetes [52]. Moreover, they are involved in proliferation and 
differentiation of cancer, for example, an increase of PPARα mRNA has 
been found in rat mammary gland carcinomas [53].  
The involvement of PPARs in cancer has been examined using 
synthetic pharmacological PPAR agonists. K.Y. Kim et al. [54] have 
showed that PPARγ activation may induce the inhibition of cell 
proliferation. In particular, they have investigated the effects of two 
different PPARγ agonists, rosiglitazone and KR-62980, on MCF-7 breast 
cancer cells. Their results showed an up-regulation of tumor suppresor 
PTEN with a decrease of Akt phosphorylation. Moreover, in PTEN 
knockdown cells, the actions of both agonists are abolished, indicating a 
key role of PTEN in the anti-proliferative effects of PPARγ activation. 
These results suggest that PPARγ activation may cause the inhibition of 
cell proliferation by apoptosis, indicating a potential role of PPARγ 
agonists in breast cancer therapy. PPARs are activated by non-covalent 
binding of both exogenous and endogenous ligands (Table 1), including 
n-3 PUFAs and various eicosanoid mediators. 
N-3 PUFAs alter PPARs cell signaling by acting as direct ligands 
for the receptors. DHA has been shown to modulate PPAR receptor 
expression, induce cellular apoptosis and inhibit cell growth [55]. Zand 
et al., have demonstrated that DHA induces apoptosis in Reh and Ramos 
cells and the apoptotic effect of DHA is regulated through PPARγ. 
Furthermore, they have found that DHA increase the expression of p53 
protein in Reh cells in a PPAR-γ-dependent manner.  
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The up-regulation of p53 protein induces apoptosis in Reh cells, 
through the activation of caspases 9 and 3, suggesting a role for p53 in 
DHA-mediated apoptosis process. These data may suggest a new 
signaling pathway, DHA-PPAR-c-p53, in regulating the apoptotic effect 
of DHA in Reh cells [56]. 
 
Exogenous PPAR ligands Endogenous PPAR ligands 
PPAR α PPAR γ PPAR α PPAR γ 
WY-14.643 Indomethacin Palmitic acid Arachidonic acid 
Clofibrate Ibuprofen Stearic acid Eicosapentaenoic 
acid 
Gemvibrozil Piroxicam Palmitoleic acid PGJ2 
Nafenopin Pioglitazon Oleic acid 15 deoxy PGJ12 
Bezafibrate Ciglitazon Linoleic acid  
 Englitazon Arachidonic acid  
 BRL-49653 Eicosapentaenoic 
acid 
 
 
Table 1. Exogenous and endogenous PPARs ligands (from Vavrušová et al., 2002 
[52]).  
 
Rovito et al., have showed that two ethanolamide derivatives 
from DHA and EPA, namely Docosahexaenoyl Ethanolamine (DHEA) 
and Eicosapentaenoyl Ethanolamine (EPEA), are able to reduce cell 
viability in MCF-7 breast cancer cells.  
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Their results showed that DHEA and EPEA treatment can 
enhance PPARγ expression, confirmed by the increased expression of its 
target gene PTEN, the inhibition of AKT-mTOR pathways and the 
induction of phosphorylation of Bcl-2 in MCF-7 breast cancer cells, 
whereas they did not elicit any effects in MCF-10A non-tumorigenic 
breast epithelial cells. In summary, their data showed that the two n-3 
ethanolamides exert anti-proliferative effects by inducing autophagy in 
breast cancer cells highlighting their potential use as breast cancer 
preventive and/or therapeutic agents [57]. 
Moreover, recent studies on human breast cancer showed that n-3 
PUFAs can up-regulate Syndecan 1 (SDC-1) synthesis by PPARγ 
transcriptional pathway [57]. SDC-1 is the major proteoglycan expressed 
on the surface of mammary epithelial cells and known to regulate many 
biological processes, including cell-cell adhesion and growth factor 
signaling [59]. Sun and coworkers have studied effects of n-3 PUFAs on 
SDC-1 expression in human mammary cell lines. In particular, they have 
observed that the treatment with n-3–PUFAs significantly increased the 
expression of SDC-1 mRNA. The activation of PPARγ determines up-
regulation of SDC-1 target gene, inducing apoptosis (Figure 1.4) [60]. 
 
 
 
Figure 1.4. The syndecan-1 pathway for n-3 PUFA induction of  apoptosis (from 
Edwards & O'Flaherty 2008 [58]). 
Dashed lines indicate that effects may be indirect with involvement of other metabolites 
and signaling molecules.  
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Nuclear transcription Factor κB (NF-κB) 
NF-κB is one of the most complex transcription factors. At 
quiescence state, NF-κB forms homo- or heterodimer usually located in 
the cytoplasm associated with an inhibitor protein (IκB). Upon 
stimulation by extracellular signals (i.e. inflammatory cytokines and 
oxidative stress) IκB is phosphorylated via kinases allowing dissociation 
from NF-κB. Phosphorylated IκB is degraded through the 
ubiquitination–proteasome pathway, while the active NF-κB dimer is 
translocated to the nucleus [61]. Abundant data support a key role for 
NF-κB signaling pathway in cell cycle activation, apoptosis, and 
carcinogenesis. In particular, the constitutive activation of NF-κB 
appears to play a role in controlling the initiation and progression of 
human cancer [62]. A large variety of extracellular signals are known to 
activate NF-κB and then the expression of 200 responsive genes [63], 
including cytokines and other proteins implicated in inflammation, such 
as COX-2, and inducible NO synthase [63], that are likely to promote the 
oncogenic phenotype (Figure 1.5).  
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Figure 1.5. NF-κB dependent targets involved in different aspects of oncogenesis 
(from Basse`res and Baldwin 2006 [65]). 
 
The regulation of the activity of pro-inflammatory transcription 
nuclear factor NF-κB is an important therapeutic effect of the major n-3 
PUFAs, EPA and DHA. Activation of NF-κB and the PPAR-Bcl-2 
feedback loop may control the life-death continuum in colon cells and 
can be further associated with the expression of COX-2.  
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Suppression of the activation of NF-κB by DHA reduces the 
production of pro-proliferative eicosanoids formed by COX-2 and also 
decreases the production of other NF-κB–induced cytokines that 
promote cancer cell growth. DHA, decreasing NF-κB activity, also 
sensitizes tumour cells to gamma irradiation and induction of apoptosis 
[66]. Moreover, Novak et al., in their experimental study, have showed 
that n-3 PUFAs can inhibit the activation of NF-κB in LPS-stimulated 
macrophage. In particular, they have demonstrate that a mechanism for 
pro-inflammatory cytokine inhibition in murine macrophages by n-3 
PUFAs is mediated, in part, through inactivation of the NF-κB signal 
transduction pathway and secondary to inhibition of IκB phosphorylation 
[67]. 
 
Alterations of cell membrane fluidity and structure 
 
The plasma membrane is involved in many aspects of cell 
biology, including proliferation, differentiation and apoptosis. Fatty 
acids in the cell membrane phospholipids (PLs) of cell membranes play 
a key role in maintaining the fluidity, structure and function of the 
membrane. Thus, changes in membrane PLs fatty acid composition can 
influence the function of cells. In particular, n-3 PUFAs incorporated 
into membrane PLs can potentially affect a variety of plasma membrane 
physical properties including membrane thickness, fluidity, elasticity, 
permeability, structure and function of membrane microdomains (lipid 
rafts) and alteration of cell signaling pathways that lead to altered 
transcription factor activity and changes in gene expression [68].  
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Here I will concentrate on the effect of DHA on membrane 
structure and function, with a major focus on membrane microdomains. 
In mammals DHA levels are not homogeneously distributed. DHA is 
found in high concentration only in select tissues, such as the retinal rod 
outer segment, sperm and neurons. DHA can approach 50 mol% of the 
total PL acyl chains in these membranes. In contrast to the few tissues 
containing high levels of DHA, there are other tissues where DHA is 
often found below 5 mol% of the total phospholipid acyl chains. In low-
DHA tissues, the PUFA-content can be influenced by dietary 
supplementation with foods rich in this n-3 FA. Probably the health 
benefits of DHA result from its incorporation into membranes that 
normally exhibit low levels of this PUFA [69]. In vitro studies have 
demonstrated that DHA can be taken up into cells and incorporated into 
plasma membrane PLs. Corsetto et al., [39] have observed that DHA is 
incorporated in breast cancer cell membrane with different specificity for 
the PLs moiety. In particular, the results showed that the concentration 
of DHA increases especially in PE (about 6,3 fold), in PI (about 7,5 fold) 
and in PC (about 26,6 fold) in MDA-MB-231 cells, while the DHA 
exposure of MCF7 cells determines the increase of DHA especially in 
PC (about 11,9 fold), in PE (about 8 fold) and in PS (about 7,3 fold). 
Moreover, they have demonstrated that the treatment with DHA 
determines a reduction of cell proliferation, inhibition of EGFR activity 
and induction of apoptotic process, suggesting that these effects might be 
the consequences of cell membrane alterations induced by FAs.  
“Lipid rafts are small (10–200nm), heterogeneous, highly 
dynamic, sterol- and sphingolipid-enriched domains that 
compartmentalize cellular processes.  
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Small rafts can sometimes be stabilized to form larger platforms 
through protein-protein and protein-lipid interactions.” [70]. The 
composition of lipid rafts is important for their function. There are 
literature evidences that the administration of DHA is able to modify the 
lipid rafts composition, in particular SM, Chol and raft-associated 
signaling proteins content, altering the lipid rafts function. The Chapkin 
laboratory assessed the effect of n-3 PUFAs on rafts lipid composition in 
multiple cell types, such as immortalized young adult mouse colonocytes 
(YAMC) and mouse splenic T-cells. In particular, they have evaluated 
the effects of n-3 PUFAs administration on Chol and SM content. Their 
results have showed a reduction of Chol (46%) and SM (30%) in YAMC 
and mouse splenic T-cells fed n-3 PUFAs, respectively [71]. Several 
reports have shown that the incorporation of n−3 PUFAs into lipid rafts 
may alter the localization and function of raft-associated signaling 
proteins by inducing changes in physical properties [72]. The Chapkin 
laboratory showed that dietary n-3 PUFAs are capable of displacing 
acylated proteins from lipid raft both in vivo and in vitro models. 
Feeding mice a diet enriched in n-3 PUFAs and treating immortalized 
young adult mouse colonocytes (YAMC) with DHA decreased the 
localization of H-Ras in lipid raft domains. Upon further examination of 
the effect of n-3 PUFAs on localization of lipid raft proteins in 
colonocytes, their lab found that DHA inhibited the plasma membrane 
targeting of lipidated proteins, including H-Ras, suggesting that changes 
in membrane lipid composition directly influence the intracellular 
trafficking and subcellular localization of lipidated proteins [72].  
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In MDA-MB-231 breast cancer cell line, Altenburg & Siddiqui, 
observed that n-3 PUFAs exposure resulted in a partial displacement of 
the chemokine receptor CXCR4 from lipid rafts. In particular, the 
treatment with n-3 PUFAs resulted in reduced surface expression of 
CXCR4, but had no effect on overall CXCR4 expression. CXCR4-
mediated signaling and migration requires thus the cholesterol-rich 
membrane microdomains. Treatment with n-3 PUFAs disrupted the 
membrane microdomains in a manner similar to methyl-β-cyclodextrin, 
suggesting that DHA, due to its incompatibility with Chol, could be the 
cause of the distruption of lipid rafts, with a partial displacement of 
CXCR4 [73]. 
The localization of Epidermal Growth Factor Receptor (EGFR) in 
lipid rafts is believed to be crucial for downstream receptor signaling 
controlling proliferation and apoptosis, which in turn could be altered by 
n-3 PUFA incorporation. Many experimental data have showed in 
several cell types that administration of n-3 PUFAs, in particular DHA, 
can exclude EGFR proteins from lipid raft, suppressing the activation of 
several downstream pathways, including ERK1/2, Akt and Fatty Acid 
Synthase (FASN) protein [74-76]. 
Chapkin et al., investigated the mechanistic link between EGFR 
function and DHA, both in vivo and in vitro. In particular, using YAMC 
cells, they observed that DHA induces shift of EGFR localization within 
the plasma membrane modifying the ability of the receptor to dimerize 
and trans-phosphorylate. In addition, DHA antagonizes the EGF-induced 
activation signaling by increasing receptor internalization and its 
degradation, and suppressing several downstream pathways, including 
Erk1/2 and STAT3.  
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Moreover, they showed that feeding a DHA-enriched diet 
resulted in an increase in EGFR phosphorylation and a suppression of 
Erk1/2 and STAT3 activation in mouse colonic epithelium.  
These data suggest that EGF/Ras/Erk signaling might be 
disrupted in DHA-treated cells by the exclusion of EGFR protein from 
lipid rafts [77]. 
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2.1 The plasma membrane 
 
The plasma membrane defines the outer perimeter of the cell and 
maintains separate the inner part of the cell and the outer environment. 
This simple fact allows at the plasma membrane to act as a selective 
permeable barrier between the cell and the extracellular environment 
regulating as well the transport of water, ions and other molecules.  
In 1925, Gorter & Grendel [78] observed that, in aqueous 
solutions, the lipids of red blood cells (RBC) were capable of forming 
bilayers, this basic organizing principle of lipid self-aggregation remains 
the oldest still valid molecular model of cellular structures. Only in 
1972, the nature of this molecular organization as a bilayer of 
amphipathic phospholipids was elucidated. Thanks to electron 
microscopy images, Singer & Nicolson proposed the "fluid mosaic" 
model of biological membranes [79]. As a key property, Singer & 
Nicolson assigned to the lipid bilayer a certain degree of fluidity. In fact, 
at physiological temperature, the phospholipids (PLs) fatty acyl chains 
are in a fluid phase. Thus, the cellular membrane appears to be a two-
dimensional solutions of integral membrane proteins in a lipid bilayer 
solvent [80,81], allowing the lateral movement of membrane 
components. Because such movements are lateral or rotational, the fatty 
acyl tails remain in the hydrophobic core of the membrane.  
Occasionally, PLs can also migrate from one leaflet of the 
membrane to the other, in a so called flip-flop movement which involves 
a head-tail inversion. However, flip-flop movements are energetically 
unfavorable because the polar head of a PL must be transported through 
the central hydrophobic interior of the membrane. 
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The membrane components can be organized in a non-
homogeneous lateral distribution, leading to obtain the “ordered 
structures that differ in lipid and/or protein composition from the 
surrounding membrane”, defined “membrane domains”. The existence 
of membrane domains with different molecular composition and 
supermolecular organization is linked to the multiple important roles 
played by biological membranes. Indeed, the biological membrane has to 
serve as a matrix for the organization of multimolecular interactions that 
are dynamic in time and space such as the signaling transduction 
pathways [82]. 
The basic matrix of eukaryotic plasma membrane is the lipid 
bilayer containing mainly amphipathic lipids such as 
glycerophospholipids (GPLs) and sphingolipids (SLs) and cholesterol 
(Chol). GPLs are the major structural lipids in cellular membranes, and 
include phosphatidylserine (PS), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), and phosphatidylcholine (PC). Their 
hydrophobic portion is a diacylglycerol (DAG), which contains saturated 
or cis-unsaturated fatty acyl chains of varying lengths. PC accounts for 
>50% of all cell membrane phospholipids, is the main bilayer-forming 
lipid. It self-organizes spontaneously as a planar bilayer in which each 
PC has a nearly cylindrical molecular geometry, with the lipidic tails 
facing each other and the polar headgroups interfacing with the aqueous 
phase. Most PC molecules have one cis-unsaturated fatty acyl chain, 
which renders them fluid at room temperature [83]. The SLs constituite 
another class of structural lipids.  
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They are defined as a category by the presence of amine-
containing lipid backbones, the so-called sphingoid bases, which are 
represented by sphingosine, the major sphingoid base found in 
mammals. Free sphingoid bases  are typically present in very small 
amounts because most are amide-linked with a long- or very-long-chain 
fatty acid to form ceramides (Cer) that can be further derivatized by 
addition of a headgroup (at C1) to form more complex sphingolipids 
such as sphingomyelin (SM), glucosylceramide (GlcCer), 
galactosylceramides (GalCer) and more complex glycosphingolipids 
(GSLs), such as gangliosides (sialic acid-containing GSLs) [84]. 
Although SLs are minor components of plasma membrane of 
mammalian cells, their local concentration can be high. Indeed, they are 
particularly abundant in certain cells and tissues such as the myelin 
sheath and neurons. Generally SLs adopt a solid “gel” phase, but are 
fluidized by sterols, which preferentially interact with them in the 
membrane. Because of their preferential interaction with Chol, SLs are 
enriched in the external side of the plasma membrane [85]. SLs have 
saturated (or trans-unsaturated) tails so they are able to form taller and 
narrower cylinders with respect to PC lipids of the same chain length and 
they pack more tightly. Moreover, SLs have extensive hydrogen-bonding 
capabilities which together with their saturated nature facilitate the 
formation of SLs-enriched lateral domains in membranes. The major SLs 
in mammalian cells are SM and the GSLs, which contain mono-, di- 
oligosaccharides based on GlcCer [86].  
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Gangliosides are typical components of neuronal plasma 
membranes. The first ganglioside structure, that of ganglioside GM1, 
was elucidated by Kuhn & Wiegand [87]. Complex GLs serve as 
adhesion sites for proteins and carbohydrates from the extracellular 
matrix and neighboring cells.  
Additionally, GLs modulate the function of the proteins on the 
same cell an often cited example is the inhibition of the Epidermal 
Growth Factor (EGF) receptor tyrosine kinase by ganglioside GM3, 
which has been suggested to be due to a glycan–glycan interaction 
involving multivalent GlcNAc termini on the EGF receptor [88]. 
Sterols are the major non-polar lipids of cell membranes, and 
Chol predominates in mammalian cell (typically accounts for 20–25% of 
the lipid molecules). The unique puckered four-ring structure of Chol 
confers special biophysical properties that increase the ordering 
(cohesion and packing) of neighbouring lipids. Because of the rigid 
sterol backbone, Chol is preferentially positioned in close proximity to 
saturated hydrocarbon chains of neighbouring lipids, as these are more 
inflexible and elongated compared with those of unsaturated lipids [89]. 
This increased lateral ordering of lipids consequently affects the 
biophysical properties of the membrane, by decreasing fluidity and 
reducing the permeability of polar molecules.  
There is a remarkable lipid asymmetry in the lipid composition of 
the two mono layers of the plasma membrane bilayer. In particular, the 
outer leaflet is enriched in SM, PC and Chol, while the inner leaflet is 
enriched in PS, PI, and PE. 
 
 
Chapter 2: Microdomain organization in cell membranes 
 
28 
 
2.2 Lipid rafts 
 
Today, the view on biological membranes has gradually evolved 
from the "fluid mosaic" model of the early 1970s to the “membrane 
microdomains” concept. The “membrane microdomains” hypothesis 
proposes that the lipid bilayer is not a structurally passive solvent, but 
that the preferential association between SLs, sterols, and specific 
proteins confers cell membranes with lateral segregation potential.  
This concept whereby the membrane lipids can be organized in 
macro- and microdomains was introduced in 1982 [90]. Subsequently, in 
1988, Simons and van Meer proposed a new concept that describes the 
formation of glycosphingolipid-cholesterol microdomains or “rafts” that 
function as transport carriers for protein and lipid from the trans-Golgi 
network (TGN) to the apical membrane of polarized epithelial cells. 
Briefly, in epithelial cells the plasma membranes are polarized into 
apical, enriched in SLs (GLs and SM), and basolateral, enriched in PC, 
[91,92] domains.  
The components of these apical and basolateral domains are 
immiscible because of the diffusion barrier formed by the tight junction 
that separates the domains. Simons & Van Meer observed in epithelial 
MDCK cells that the delivery and sorting of newly synthesized SLs 
takes place in the TGN and that these lipids are preferentially sorted to 
the apical membrane [93]. The hypothesis postulated that favorable 
molecular interactions induce the formation of cholesterol-sphingolipid-
enriched domains, referred to as “lipid rafts”, within the plasma 
membrane [94].  
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Moreover, the difference in each membrane protein’s affinity for 
raft and non-raft lipid species regulates their localization within the 
plasma membrane, and, consequently, its proximity to potential binding 
partners.  
One subset of lipid rafts is found in cell surface invaginations 
called caveolae. These flask-shaped plasma membrane invaginations 
were firsty identified on the basis of their morphology by Palade and 
Yamada in the 1950s. Caveolae are formed from lipid rafts by 
polymerization of caveolins-hairpin-like palmitoylated integral 
membrane proteins that tightly bind cholesterol. They have been 
implicated in endocytosis of albumin and other proteins across the 
endothelial monolayer. Moreover, they also function during signal 
transduction, but they are not absolutely required as several cell types 
that lack caveolin, such as lymphocytes and neurons, can nevertheless 
signal through rafts [95]. 
“Lipid rafts” were initially proposed to function in sorting and 
transport of lipids and proteins as well as in signal transduction [94]. 
During the past two decades, the concept of “lipid rafts” has become 
extremely popular among cell biologists, and these structures have been 
suggested to be involved in a great variety of cellular functions and 
biological events, and the definition of a “lipid raft” has been revised. 
Today, “lipid rafts” are defined as small, dynamic, ordered domains of 
cholesterol, sphingolipids, and specific proteins that may combine into 
larger structures due to lipid–lipid, lipid–protein, and protein–protein 
interactions that are hypothesized to exist in the plasma membranes of 
eukaryotic cells [96,97]. 
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2.2.1 Lipid phase behavior and raft formation 
 
Under physiological conditions, lipid bilayers exist in a liquid 
disordered (Ld) phase, upon cooling below the melting point, the lipid 
acyl chains are frozen in an solid-ordered phase (So) where their 
mobility is restricted. However, because of the high concentration of 
Chol in the plasma membrane, a third physical phase, the liquid ordered 
(Lo) phase [98], can be observed. In the Lo state, acyl chains of lipids 
are extended and tightly packed. In this sense, the Lo state is similar to 
the gel state, and lipids that favor gel state formation, and thus have a 
high melting temperature (Tm) in the absence of Chol, tend to form the 
Lo state in the presence of Chol.  
 
 
 
Figure 2.1. Lipid phases in membranes (from van Meer et al., 2008 [83]). 
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On the other hand, lateral diffusion in the Lo state appears to be 
almost as rapid as in the fluid Ld state (Figure 2.1). Thus, in a sense the 
Lo state has properties intermediate between gel and Ld states [99]. The 
“lipid rafts” structure appears to arise from the phase separation of a Ld 
phase and a cholesterol-rich Lo phase. The first, non-rafts phase consists 
mainly of the unsaturated lipid and is depleted of Chol; the second, raft-
like phase is enriched in both Chol and high Tm lipids such as SM [100].  
The membrane lipids are highly heterogeneous in their 
hydrophobic portions: GPLs contain unsaturated acyl chains that ensures 
the fluidity of biological bilayers, while, SLs (e.g. SM) have long and 
saturated acyl chains and this allows them to be tightly packed with a 
high degree of order in the hydrophobic core of a bilayer, obtaining 
much higher Tm than membrane PLs.  
It is now clear that tight acyl chain packing is a key feature of 
membrane microdomain organization [101]. In fact, the differential 
packing ability of SLs and phospholipids is most likely one of the major 
forces leading to phase separation in lipid mixtures, including bilayers. 
The coexistence of domains in Lo and Ld phases has been 
extensively characterized. Studies of membrane model systems strongly 
suggest that lipids could laterally segregate in membranes under certain 
conditions, and could form distinct lipid domains with particular 
structural characteristics (i.e. a particular lipid phase). Early evidence of 
fluid phase separation was reported in the early 1970s by Phillips et al., 
who evaluated lateral mixing of different PC species using differential 
scanning calorimetry (DSC) [102]. 
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Two phase coexistence in binary mixtures of a lipid with 
cholesterol was observed by Shimshick & McConnell who mapped out 
phase diagrams for lateral phase separation by using electron spin 
resonance (ESR) [103]. Moreover, using nuclear magnetic resonance 
(NMR), Schmidt et al., have observed that sphingomyelin might form 
microdomains in biological membranes [104]. Gebhardt et al., 
considered the known lipid compositional heterogeneity in biological 
membranes and predicted that lipid lateral segregation might occur under 
particular environmental conditions such as those that mimic a 
physiological state [105]. 
More recently, using a variety of techniques, such as 
Fluorescence Resonance Energy Transfer (FRET), Deuterium-based 
Nuclear Magnetic Resonance (
2
H-NMR) and Atomic Force Microcopy 
(AFM), it is possible to observe macroscopic (>200nm) or microscopic 
(<100nm) separation of Lo and Ld phases [106]. For example, donor-
quenching FRET analysis shows nanoscale domain formation (a few 
tens of nm) in lipid bilayers with a similar composition to that of the 
outer plasma membrane, at physiological temperature [107]. 
AFM has been extensively used for topographic characterization 
of membrane models, and in particular, for identification and 
visualization of lipid domains and phase transitions in monolayers and in 
supported lipid bilayers (SLBs) [108]. Tokumasu et al., have observed 
that nanoscopic and microscopic domains can coexist under a range of 
composition mixtures at room temperature with or without cholesterol in 
membrane bilayers from a DLPC/DPPC/Chol [109].  
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Yuan et al., have studied the distribution of ganglioside GM1 in 
model membranes composed of ternary lipid mixtures (SM/Chol/DOPC) 
that mimic the composition of lipid rafts. Their results demonstrate that 
addition of GM1 to lipid monolayers leads to the formation of small 
ganglioside-rich microdomains, with lateral dimension in the order of a 
few tens of nm, that are localized preferentially in the ordered SM/Chol-
rich phase [110].  
 A number of lipid mixtures have been used to mimic the 
biophysical characteristics of rafts in membrane model systems. Recent 
studies have confirmed the importance of using natural raft mixtures rich 
in SM (synthetic 16:0 or natural), Chol and in some cases small amounts 
of the ganglioside GM1 compared to mixtures containing raft lipid 
“model” such as DPPC. Ternary mixtures designed to mimic the 
coexisting of raft and non-raft domains are usually composed of Chol, 
SM and unsaturated phospholipids (DOPC or POPC) [111].  
It is generally believed that the interaction of DOPC with the high 
melting lipid is so unfavorable that over an extensive region of 
composition space, phase separation of Ld and Lo occurs. Phase 
domains are macroscopic, and a single domain can extend also for some 
microns due to the effective local cholesterol concentration [112-114]. 
Indeed varying the Chol content from ~10% to 35% progressively 
increases the size of Lo domains from small (<20nm), through 
intermediate sizes (20–75 nm) detected by FRET imaging, to larger 
domains (>100 nm) that are visible by standard microscopy [115]. 
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Chol has important effects on phase behavior. In particular, in the 
Lo phase, cholesterol is preferentially positioned in close proximity to 
saturated hydrocarbon chains of the bilayer-forming lipid, as these are 
more inflexible and elongated compared with those of unsaturated lipids, 
so increasing the ordering (cohesion and packing) of neighbouring lipids 
[82,101]. Precisely how Chol drives the  formation of the Lo phase 
remains unclear. Several schemes, derived from in vitro studies, have 
been generated to explain the mechanisms of Chol–lipid interactions 
(Figure 2.2).  
 
 
 
Figure 2.2. Models of cholesterol interactions with other lipids (from Ikonen 2008 
[116]. 
 
In the “condensed complex model” McConnell et al., have 
suggested that cholesterol can form reversible oligomeric chemical 
complexes with phospholipids. The formation of these complexes has 
been proposed to lead to the “condensing” effect of Chol, in the other 
words the surface area occupied by the PLs is decreased by interaction 
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with Chol [117]. While Huang & Feigenson have presented another 
model of Chol-phospholipid mixing: the “umbrella model” [118,119]. 
They propose a model in which non-polar Chol relies on the coverage of 
polar headgroups of the neighboring PL to prevent the unfavorable free 
energy of exposure of the non polar body part to water. Chol is generally 
regarded as a key lipid component of “lipid rafts” [97]. However, 
understanding the role of Chol in stabilizing membrane domains is 
hampered by the lack of precise information regarding its trans-bilayer 
distribution, which is largely asymmetric [120]. Importantly, in 
membranes that comprise appropriate mixtures of SM, unsaturated 
phospholipids and Chol, Lo and Ld phases can coexist [115]. 
Model systems have greatly improved our understanding of the 
structure and function of cell membranes, but the membrane model does 
not reflect the complexity of the lipid environment or the interactions 
between lipids and proteins in a cell membrane. The main reason for this 
difference is that model systems are too simplistic to simulate all the 
chemical complexity of the cell membrane. Indeed, the plasma 
membrane contains a plethora of lipid-anchored and transmembrane 
proteins, is not a static platform and cannot be considered an equilibrated 
membrane. Moreover, there is a remarkable lipid asymmetry in the lipid 
composition of the two mono layers of the plasma membrane, and the 
cholesterol is excluded from the immediate vicinity of transmembrane 
proteins; therefore the local concentration of cholesterol will vary on a 
nanometer-length scale [121]. For these reasons, became particularly 
important the introduction of giant plasma membrane vesicles (GPMVs), 
microscopic spheres of plasma membranes harvested from live cells 
following chemical treatment [122].  
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They are probably the closest models of cell plasma membranes 
in terms of chemical composition, as in addition to lipids they contain 
also membrane proteins. Fluid phase separation has been reported in 
giant GPMVs obtained from mast cells and fibroblasts [123-125], from 
CHO-K1 [126], RBL-2H3 [127] and A431 cells [128]. 
For example, in a study of GPMVs composed of native 
pulmonary surfactant membranes, Bernardino de la Serna  [129] 
observed by Fluorescence Microscopy (FM) and AFM under 
physiological conditions, that the native material showed the coexistence 
of two distinct micrometer sized fluid phases, ordered and disordered-
like phases. Their results provide a clear example of the notion that 
specialized regions with particular lateral packing properties coexist in 
natural membranes and control specific molecular interactions in 
agreement with the raft hypothesis. Moreover, they have obtained 
evidence that at physiological temperature the observed lateral structure 
in native pulmonary surfactant membranes is dependent on the 
concentration of a few key lipid species. In particular, the phase 
separation is dramatically affected by the extraction of cholesterol, an 
effect not observed upon extraction of the surfactant proteins. These 
GPMVs offer an good opportunity to study the phase preference of lipids 
and proteins in complex biological membranes. However, even GPMVs 
are not perfect models of plasma membranes of live cells.  
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Recent studies suggest that the amount of Lo phase in plasma 
membranes of eukaryotic live cells can be significantly above 50% 
[130], while this is clearly not the case in GPMVs [131]. 
Membrane models and giant plasma membrane vesicles show 
clearly separated microscopic domains of Lo/Ld phases, while in cell 
plasma membranes these domains have not been really observed except 
in some rare exceptions [132,133]. In particular, Gaus et al., have 
directly visualized membrane lipid structure of living cells by using two-
photon microscopy at physiological temperature. In particular, in 
macrophages, Lo domains were particularly enriched on membrane 
protrusions and cover 10-15% of the cell surface. Finally, by 
deconvoluting the images, they have demonstrated the existence of phase 
separation in vivo, thereby providing strong support for the lipid raft 
hypothesis [132]. 
However, in live cells, the domains are probably too small and 
dynamic, so that only recently introduced super-resolution techniques 
may access these tiny enigmatic structures [134,135]. 
 
2.2.2 Lipid rafts isolated as Detergent-Resistant Membranes 
(DRMs) 
 
To biochemically demonstrate an association between the locally 
concentrated membrane proteins and lipids, Brown & Rose (Brown & 
Rose, 1992) described a simple detergent extraction method where they 
demonstrated that GPI-anchored proteins can be inserted in detergent-
resistant membranes or DRMs. This was the first evidence supporting 
the "lipid raft" hypothesis of Simons & van Meer [92].  
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These insoluble membranes appear to derive from cholesterol-
sphingolipid-rich membrane microdomains (rafts) in the tightly packed 
Lo state. Furthermore, experiments on membrane models under the 
conditions used to extract cells show that monolayers and bilayers SM 
and Chol content are more resistant to solubilization by Triton X-100 
than the pure membrane SM. Hydrogen bonding between cholesterol and 
SM may be important for this, and can provide a rational explanation for 
the detergent insolubility of DRMs [136].  
Thus, there is a close relation between rafts and DRMs, and 
isolation of DRMs is became one of the most widely used methods for 
studying lipid rafts. 
The standard method of isolation of membrane rafts involves 
solubilization of the membrane at 4°C using the non-ionic detergent, 
typically Triton X-100. Due to their low relative density, due to of their 
high lipid-to-protein ratio, membrane rafts are separated by 
centrifugation on discontinuous or continuous sucrose gradients (usually 
DRMs are isolated in the low-density fractions corresponding to the 5% 
and 30% sucrose interface) [137,138]. Low-density detergent-insoluble 
fractions were isolated from a wide variety of cultured cells, including 
almost all the mammalian cell types [139-141], yeast [142], and plant 
cells [143]. 
Analyses of this type of raft preparation have revealed a 
membrane domain of unique lipid composition. Thus Triton-X-100-
resistant lipid rafts are distinguished from bulk plasma membrane 
because they are enriched in Chol and SLs, but are relatively depleted in 
GPLs [144,145]. 
 
Chapter 2: Microdomain organization in cell membranes 
 
39 
 
As report above (section 2.2.1), under physiological conditions, 
lipid bilayers exist in a Ld phase, upon cooling below the melting point, 
the lipid acyl chains are frozen in an solid-ordered phase (So) where 
their mobility is restricted. However, because of the high concentration 
of Chol in the plasma membrane, a third physical phase, the Lo phase 
can be observed. The Lo phase is characterized by a high order degree of 
lipid acyl chains (as in the So phase), but with higher lateral mobility 
(characteristic of Ld phase). GPLs present in the membrane in a Ld 
phase are dissolved by treatment with non-ionic detergent at low 
temperature, and they are thus removed from the membrane through the 
formation of mixed detergent/lipid micelles [146]. While Lo phase 
components are insoluble in Triton X-100, and they remain thus  
laterally organized in microsome-like or planar structures, as shown 
schematically in Figure 2.3 [147]. 
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Figure 2.3. Insolubility of lipid raft components in the presence of Triton X-100 and 
preparation of DRMs (from Sonnino & Prinetti 2013 [82]). 
 
Although Triton X-100 is the best characterized and most widely 
used detergent for DRM purification, other isolation procedures which 
involve the use of different detergents including Lubrol WX, Brij 96, 
Brij 98, Nonidet P40 and CHAPS have been used to prepare detergent 
resistant membrane domains [148-151]. The use of these different 
detergents in the preparation of rafts yields membrane domains with 
lipid compositions different from those of standard Triton-X-100-
resistant membranes. For example, Schuck et al., [152] observed that 
rafts prepared in Triton X-100 were strongly enriched in SLs and Chol as 
compared with total cell membranes, while, extraction with Tween 20, 
Brij 58 or Lubrol WX yielded low density membranes that showed 
relatively little enrichment in either of these traditional raft lipids. 
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Moreover, DRMs prepared with Brij 96 or Brij 98 were 
moderately enriched in Chol and SM. In conclusion, Schuck et al., 
described these differences as being due to the "DRM selectivities" of 
the different detergents, where, Triton X-100 was the most selective, 
whereas Tween 20 and Brij 58 were the least selective. Moreover, use of 
mild detergents such as Brij 98 is preferable, compared with Triton X-
100, because it has a reduced tendency to solubilise PLs localized in the 
inner leaflet or cause fusion of membrane fragments from different 
sources to form an amalgamated detergent-resistant membrane [153]. 
The observation that different detergents can lead to the isolation of 
DRMs with different composition suggests that there is some underlying 
heterogeneity among rafts that gives rise to these differences. 
A variety of studies have suggested that detergent extraction (in 
particular Triton X-100) causes fusion of rafts, as well as lipid exchange 
between membranes [154-156]. 
Heerklotz et al., suggested that Triton X-100 could induce 
domain formation in POPC/SM/Chol raft model membrane system 
(otherwise miscible lipid mixtures). NMR and calorimetric 
measurements were used to follow micellization of lipids, an indication 
of membrane solubilization, as a function of temperature and Triton X-
100 concentration and thermal transitions. Their results suggest that the 
large SM/Chol-rich domains isolated from detergent do not reliably 
report on the organization of these lipids in the cell membrane [157]. 
Nevertheless recent data demonstrated that Triton X-100 does not induce 
domain formation or increase the fraction of the bilayer in the ordered 
state, although it does increase domain size by coalescing pre-existing 
domains [158].  
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These results have important implications for the reliability of 
Triton X-100 insolubility as a method to detect ordered domains. 
Another problem associated with the use of Triton X-100 is the 
possibility that of treatment with detergents might generate clusters of 
raft lipids and proteins that did not exist in the intact cells [159]. Cross-
linking experiments showed that GPI-anchored proteins aggregate into 
large clusters in the presence of detergent, but not in its absence [160]. 
To avoid the complications associated with preparing lipid rafts 
using detergent extraction procedures, several “detergent-free” methods 
have been established. Mcdonald & Pike [161], developed a simplified 
and rapid method for the purification of detergent-free lipid rafts, 
starting from the protocols of Song et al., and Smart et al., [162,163]. 
Briefly, Chinese hamster ovary (CHO) and HeLa cells were lysed by 
passage through a needle. Lysates were centrifuged and the resulting 
postnuclear supernatant was mixed with an equal volume of  buffer 
containing OptiPrep™. A 0% to 20% continuous OptiPrep™ gradient 
was poured on top of the lysate. The gradient was centrifuged for 90 min 
at 52,000 g and different fractions were collected. This method yields a 
membrane fraction that is highly enriched in cholesterol and protein 
markers of lipid rafts, with no contamination from non-raft plasma 
membrane or intracellular membranes. Other detergent-free methods 
have used sodium carbonate and OptiPrep™; magnetic bead; or silica-
based isolations using raft/caveolar proteins as markers or the use of 
cationic buffers, which may stabilize raft-associated proteins [164, 165]. 
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These preparations seem to retain a greater fraction of inner 
leaflet membrane lipids [144] than DRM rafts and may therefore yield 
domains in which the coupling between raft leaflets is maintained. [166-
168]. For these reasons, rafts prepared by non-detergent methods seem 
more likely to reproduce the in vivo composition of these microdomains 
accurately. Comparative analyses have shown that the compositions of 
DRM versus non-detergent membrane fractions obtained after cell lysis 
under different experimental conditions appear to be similar but not 
identical [144]. 
The finding that non-detergent rafts are similar to some forms of 
detergent resistant rafts suggests that there is some overlap in the type of 
domain that is being isolated by these different methods. In particular, 
these results suggest that the highly ordered supramolecular structures 
corresponding to the native cores of lipid rafts can be isolated using 
these procedures, despite the procedures can alter the lateral order of 
biological membranes to some extent [82]. 
Several reviews on the different methods of isolation of 
membrane lipid rafts are available for the interested reader [169,170]. 
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2.2.3 The organization of proteins within the lipid rafts 
 
According to the lipid raft hypothesis, cholesterol- and 
sphingolipid-enriched domains can modulate protein–protein 
interactions, in particular, lipid rafts can include or exclude proteins, for 
this reason, they may be involved in the regulation of different cellular 
processes. While most of the cell membrane proteins are found in non-
raft domains, some proteins are preferentially concentrated into the raft 
domains.  
As examples include glycosylphosphatidylinositol-linked proteins 
(GPI), which are anchored to the outer leaflet of the membrane by the 
GPI anchor, palmitoylated/myristoylated proteins such as flotillins [171], 
which are localized to the inner leaflet of the membrane and probably 
function as raft organizers. In addition, many proteins associated with 
rafts are receptors or proteins involved in signal transduction, such as the 
Epidermal Growth Factor Receptor (EGFR) [95].  
Post-translational modifications allow for rapid modulation of 
protein structure, localization, and function. An important class is lipid 
modifications, which includes the addition of saturated lipids or specific 
targeting sequence (e.g., a cholesterol-binding). The cellular purpose of 
protein lipidation is often to anchor the modified polypeptide to 
membranes. Several evidence suggest that a protein lipidation can 
increase the concentration of both, peripheral and transmembrane 
proteins within rafts, while short, unsaturated, and/or branched 
hydrocarbon chains prevent raft association [172]. The well-
characterized examples of lipid modifications determining protein 
association with membrane rafts are GPI-anchored proteins.  
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Several experimental data confirm that GPI-anchored proteins are 
concentrated into lipid rafts by virtue of the interaction of their 
hydrophobic anchors with raft domains. Varma & Mayor using FRET 
showed that GPI-anchored folate receptors attached to a fluorescent folic 
acid analogue were clustered in domains of a size less than 70nm. 
Moreover, depleting the cell membrane of Chol resulted in a decreased 
FRET efficiency, consistent with an increased distance between folate 
receptors. Addition of Chol to the cell resulted in restoration of the 
proteins to ordered domains. These results confirmed that lipid-linked 
proteins are organized in Chol-dependent submicron sized domains 
[173]. An direct measure of component partitioning between coexisting 
fluid domains has been provided by observations of reconstituted 
proteins in model membranes containing a phase separating mixture of 
raft lipids (SM, an unsaturated phosphatidylcholine, and Chol). For 
example, GPI-AP Thy-1 reconstituted in model membranes showed a 
significant distribution into the model raft domain [174]. Similar results 
have been obtained observing GPI-AP placental alkaline phosphatase 
(PLAP) into a model bilayer; here PLAP partitioned into the ordered 
phase and this partitioning can be greatly enhanced by antibody-
mediated oligomerization [175]. 
Cysteine S-palmitoylation, another raft-targeting motif, can 
increase an affinity of protein for rafts [176]. Indeed, membrane proteins 
can be reversibly palmitoylated and can lose its raft association after 
depalmitoylation. Palmitoylation and rafts association were shown for 
Src-family of kinases (SFKs) Lck and its substrate Fyn [177], for the T-
cell transmembrane co-receptor CD4 [178] and for the cytotoxic T-cell 
co-receptor component CD8β [179].  
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An important class of intracellular proteins whose raft association 
appears to be mediated by palmitoylation are GTP-binding switches, 
including small GTPases of the Ras family [180]. Prior et al., combining 
detergent resistance, non detergent fractionation, antibody patching, and 
Electron Microscopy (EM) have showed that the doubly palmitoylated 
H-Ras was raft associated, whereas K-Ras, the non-palmitoylated 
isoform, was excluded from these microdomains [168, 180]. 
 
2.2.3 Lipid rafts and signal transduction: the EGFR pathway 
 
The lipid raft has become extremely popular and has been 
implicated in a wide variety of cellular functions and biological events 
[181,182] such as membrane trafficking, signal transduction, and 
regulation of the activity of membrane proteins [95,183]. As shows in 
Table 2.1, several classes of proteins, identified by biophysical, 
biochemical, and immuno-localization methods, and involved in signal 
transduction mechanisms, have been reported to be associated with lipid 
rafts.  
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Table 2.1. Examples of protein components of lipid rafts (from Simons &Toomre 
2000 [95]). 
 
The EGFR is a 170 kDa transmembrane tyrosine kinase receptor. 
It is synthesized from a 1210 amino acid polypeptide precursor; after 
cleavage of the N-terminal sequence, an 1186-residue protein is inserted 
into the cell membrane. EGF receptors have a highly conserved 
extracellular binding domain, a single transmembrane lipophilic region, 
and a cytoplasmic tyrosine kinase domain [184].  
Several ligands, including EGF, transforming growth factor-alpha 
(TGF-α), epiregulin (EPR) and betacellulin bind and activate the EGFR 
receptors [185].  
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Upon ligand binding, EGF receptors form homo or heterodimers 
that, following trans-phosphorylation of their intracellular tyrosine 
kinase domains, recruit signaling proteins, such as Shc, Grb7, Grb2, the 
phospholipase Cγ (PLCγ), the intracellular kinases Src and PI3K, 
responsible for the initiation of several signaling pathways. These 
intracellular signaling cascades result in alterations of gene expression, 
which determine the biological response to receptor activation. 
The EGFR signaling has multiple routers, as shown in Figure 
2.4. The two major downstream signalling pathways includes the 
Ras/Raf/mitogen-activated protein kinase (MAPK) for proliferation and 
the phosphatidylinositol 3-kinase (PI3K)/Akt for survival [186-188]. 
The Ras/Raf/mitogen-activated protein kinase (MAPK) pathway 
is well-characterised. This begins with the recruitment of Grb2, that can 
bind either directly to the phosphorylated EGFR. Grb2 is constitutively 
bound to the Ras exchange factor Sos and is normally localized to the 
cytosol. Relocation of the Grb2/Sos complex to the receptor at the 
plasma membrane facilitates the interaction of membrane-associated Ras 
with Sos, resulting in activation of Ras via the exchange of its associated 
GDP with GTP. Ras in turn activates the serine/threonine kinase Raf-1, 
which leads to the activation of the MAPK pathway.  
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Figure 2.1. EGFR signaling (from Ayyappan et al., 2013 [189]). 
Intracellular signaling pathways include RAS/ Raf-1/ MAPK, PI3K/AKT, PLCγ/PKC 
pathways which require the adaptor molecules for signaling. Src and STAT pathways are 
directly activated by phosphorylated receptors.  
 
This involves the phosphorylation of MEK (MAPKinase) and the 
activation and translocation of Erk1 and Erk2 to the nucleus, where they 
phosphorylate transcription factors, such as Elk, stimulating cell 
proliferation and motility [190]. Another EGFR signaling pathway, is the 
PI3K/Akt pathway. PI3K can be activated by K-Ras or by EGFR itself. 
PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to 
phosphatidylinositol 3,4,5-trisphosphate (PIP3) that stimulates the 
activity of serine/threonine kinase Akt (also known as protein kinase B) 
by binding to its Pleckstrin Homology (PH) domain.  
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Akt can phosphorylate proteins such as CREB (cAMP response 
element binding protein), pro-caspase-9, BAD and is involved in the 
regulation of apoptosis, gene expression, cell proliferation migration and 
angiogenesis [191,192]. As mentioned above, lipid rafts are enriched in 
Chol, SLs, and saturated FAs, characterized by higher order, that 
function as signaling platforms [95,96]. The ability of EGFR to activate 
downstream pathways is its localization in lipid raft domains of the 
plasma membrane [193-195] probably due to co-localization with 
downstream mediators within lipid rafts. In addition, disruption of lipid 
rafts results in the re-localization of EGFR to bulk membrane regions, 
which alters EGFR activation and signaling [77]. EGFR is an important 
mediator of cancer cell proliferation, differentiation and survival; indeed, 
overexpression or activation of EGFR has been strongly linked to the 
etiology of several human cancers, including esophago-gastric [189] and 
breast cancer [196]. 
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3.1 Developments in microscopy 
 
A growing need for techniques to study the basis of essential 
processes for life in even greater detail were developed in the last 
decades. A wide variety of biochemical techniques is now available to 
allow a functional study of the molecular origin of these processes. 
However, there are only a limited number of tools available to study the 
structure of biomolecules, which are generally only few µm large. 
Conventional optical microscopes use light beams to image objects. 
Their spatial resolution is limited by the used wavelengths. For this 
reason it is not possible to visualize the structure of individual 
biomolecules and their complexes. X-ray scattering techniques have 
contributed a lot to the structural determination of biomolecules. Using 
these techniques, Crick and Watson discovered the DNA double helix 
structure in 1954, thanks to the analysis of the crystal diffraction pattern 
[197]. Nowadays a great number of biomolecules have been structurally 
resolved with atomic resolution using X-ray crystallography. 
Unfortunately these techniques usually resolve only an average crystal 
structure, neglecting the dynamics of molecular processes. Moreover, 
not all proteins can be crystallized. The hydrophilic environment of 
crystallization can also modify the physiological conformation of the 
protein, which happens in the case of transmembrane proteins.  
In 1960, the invention of the Electron Microscope (EM), allowed 
the observation of nanometer-sized objects such as DNA, proteins and 
other biological macromolecules.  
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However, because the biological matter is transparent compared 
with an electron beam, the sample must be frozen, fixed, dried, and/or 
processed to gain contrast prior to imaging. The use of these invasive 
treatments limits the possibility of applying this technique to study 
samples in physiological conditions as well as to study the dynamic 
processes. Many other techniques were also developed to obtain more 
information regarding the dynamics of biological processes such as the 
molecular motion, conformational changes and interaction receptor-
ligand. Some examples are the use of optical dichroism studies to 
measure molecular motion, and fluorescence quenching experiments to 
get information about the interaction of proteins. Obviously, all these 
techniques offer information about few, very specific aspects of the 
system under study. Moreover, the biological system must be prepared 
(and often denatured) in order to make it accessible to a particular 
method of analysis. In microscopy, many invasive sample preparations 
can be found, such as drying of the samples for EM investigations and 
metal coating in the case of Scanning Electron Microscopy (SEM) 
imaging. 
The imaging and the manipulation of molecules at the atomic 
scale have been a dream become true at the early 80’s with a new 
revolutionary kind of microscopy known as Scanning Probe Microscopy 
(SPM). SPM, a branch of non-optical microscopy, has rapidly evolved 
into a family of powerful techniques able to visualize the sample surface 
with high resolution, down to the level of molecules and groups of 
atoms, in three dimensions.  
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A wide variety of materials, including biological systems, can be 
measured and many surface properties that other microscopes cannot 
see, can be studied by SPM.  
SPM uses no light or focused electrons, but rather an extremely 
sharp tip (10-50nm radius of curvature) mounted on a flexible cantilever, 
allowing the tip to follow the surface profile. The interactions between 
the tip and the atoms composing the sample surface can be recorded and 
processed to form 3D image of sample surface. The invention of the 
Scanning Tunneling Microscopy (STM) in 1982 by Binnig et al., at the 
IBM Zurich Research Laboratory allowed to study surfaces of solid 
materials at atomic scale [198], imaging individual atoms and molecules. 
For this reason, the developments in SPM have led to the birth of a new 
techniques such as Atomic Force Microscopy (AFM) and Near-field 
Scanning Optical Microscope (NSOM). 
Today, new high-resolution imaging methods (e.g. Fluorescence 
Resonance Energy Transfer (FRET), Fluorescence Correlation 
Spectroscopy (FCS) and Stimulated Emission Depletion (STED) 
Microscopy have allowed advances in the membrane research, such as 
evaluation of lipid–lipid and lipid–protein interactions in the cell bilayer. 
The use of these new high-resolution imaging methods to study 
membrane microdomains are extensively described in a recent review  
[82,97]. 
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3.2 Atomic Force Microscope (AFM) 
 
AFM was developed in a collaboration between IBM Zurich 
Research Laboratory and Stanford University in 1986 by Binnig, Quate 
& Gerber [199]. The success of AFM has been its capability to 
overcome the main drawback of the STM technique, namely the 
requirement to have a conductive surface. AFM is now the most versatile 
branch of Scanning Probe Microscopy (SPM) to study samples 
regardless of their conductive properties. AFM is able to collect 3D 
topography images with high lateral and vertical resolutions, in the order 
of nanometre, without any sample preparation such as fixation, staining, 
or labeling. In addition, AFM can visualize samples in air and liquid 
without the need to operate under vacuum. AFM can analyze almost any 
type of surface: ceramics, polymers, synthetic and biological 
membranes, biological macromolecules like nucleic acids and proteins, 
cells and tissues, metals, glass and semiconductors.  
Since its invention, the number of publications related to AFM 
has increasing constantly, and the instrument is now a fundamental tool 
in several fields of research, from biochemistry to biology, from 
materials science to engineering, in studies of the most varied 
phenomena, such as characterization of nanostructures and molecules 
[200], surface elasticity [201], and friction [202]. In biological field, in 
the last 20 years, AFM has been used to visualize cells, membranes and 
smallest biomolecules, such as proteins, phospholipids, RNA and DNA 
under near-physiological conditions [203-206].  
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Besides imaging, AFM allowed to measure mechanical properties 
of biological samples like elasticity and stiffness and it has been used for 
manipulation of individual biomolecules [207-210]. 
 
3.2.1 Functional principles 
 
Traditional microscopes use electromagnetic radiation, such as 
photon or electron beams, to create an image. On the contrary AFM is a 
mechanical imaging instrument that collects three-dimensional 
topography images as well as physical properties of a surface with a thin 
probe. Figure 4.1 shows a typical AFM set up composed of a cantilever-
tip assembly and an optical detector to evaluate the cantilever bending 
induced by the forces interacting between the tip and the sample surface. 
The sample is scanned in three-dimensions (X,Y,Z) by the AFM probe 
with angstrom precision. 
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Figure 4.1. Scheme of an Atomic Force Microscope (AFM).  
It shows the scanning probe, the piezo electric scanner and the laser deflection system. 
 
The AFM heart is the scanning probe, composed of a tip, mounted at the 
end of a flexible cantilever (Figure 4.2). The tip is the part that interacts 
directly with the sample, and is used to scan its surface, senses the 
topographical variations of the sample surface, and generates three 
dimensional images. 
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Figure 3.2. AFM probe. 
In particular the picture shows a V-shaped cantilever. Scale bar: 200nm. 
 
In 1986, Binnig et al., built the first AFM tip-cantilever system 
based on a tiny shard of diamond glued at the end of a rectangular strip 
of gold foil [199]. This construction allowed to resolve lateral features as 
small as 30nm. The structural resolution of AFM depends strongly on 
the sharpness of the tip [211] and therefore the technical developments 
have been focused on improving the performances of this component. 
The ideal AFM tip should have a high aspect ratio (ratio between height 
and width of the tip) with a radius of curvature as small as possible, a 
pyramidal or conical geometry which makes the terminal point of the tip 
very sharp in order to be able to penetrate in small pits of the surface. 
Moreover, it should be mechanically and chemically robust so that its 
structure is not altered while imaging in air or fluid environments.  
Today, the typical tip-cantilever assembly is micro-fabricated 
from silicon (Si) or silicon nitride (Si3N4). The tips are pyramidal in 
shape with cone angles of 20–30° and radius of curvature of 5–10nm 
(Si) or 20–60nm (Si3N4).  
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The cantilevers are mainly of two shapes: rectangular and V-
shaped [212]. Moreover, their were coated with a thin layer of gold on 
the backside (the one not in closest proximity with the sample) to 
enhance its reflectivity.  
The cantilever should have: 
 
 a relatively low spring constant, typically between 0.1 and 
10N/m, enabling to measure a deflection caused to a small 
force; 
 high resonance frequency to minimize the sensitivity of the 
cantilever to mechanic vibrations of low frequency (around 10-
100kHz); 
 high lateral stiffness to reduce the effect of lateral forces. 
 
To describe the topography of the sample, the tip is raster scanned over 
the object surface, and the cantilever deflection is simultaneously 
recorded. Interaction forces between the tip and the sample surface cause 
a vertical deflection of the cantilever according to Hooke’s law:  
 
F = k x 
 
where k is the spring constant of the cantilever (N/m), and x the 
cantilever vertical deflection (nm). 
The interaction forces are evaluated using the force curves, which 
reflect the relationship between the cantilever deflection and the vertical 
movements of the cantilever.  
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The cantilever deflection is measured by an optical detection 
system like optical lever method, with sub-angstrom sensitivity 
[213,214]. The scanning over an uneven surface causes the cantilever 
deflection, which is measured by focusing a laser beam on the back of 
cantilever and its upward and downward deviations are collected on a 
rotating mirror and into a position sensitive detector (PSD, Figure 4.3). 
The direction of the reflected laser beam is sensed by the PSD, which is 
typically divided in four quadrants, as illustrated in Figure 4.3. The 
optical lever is a mechanical amplifier which is able to increase the 
movements of the tip generating an extremely high sensitivity. The 
sensitivity of this detection system is in the order  of 10
-3
 Å/(Hz)
1/2
, both 
for deflection and torsion of the cantilever [215]. Using this method, the 
vertical deflection of the cantilever can be monitored. In particular, when 
the cantilever is in rest position, the reflected laser beam should be 
centred on the PSD (red spot in Figure 4.3). During the scanning, the 
vertical deflection of the cantilever, due to attractive or repulsive 
interactions of the tip with the sample surface, causes a vertical shift of 
the beam spot on the PSD (occupying the position indicated in blue in 
Figure 4.3). 
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Figure 4.3. Position sensitive detector (PSD) divided in four quadrants A, B, C and D, 
employed in the optical detection method. 
 
Moreover, the optical detection system allows measuring 
frictional forces acting on the tip [216]: these are manifested in a lateral 
shift of the laser beam spot (green spots in Figure 4.3). The vertical or 
lateral movements of the laser spot are detected by calculating the 
differences of the signal due to the different quadrants of the PSD. The 
differences in signal in the vertical and horizontal direction are 
proportional to the vertical and torsional deflection of the cantilever 
respectively. 
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3.2.2 AFM imaging mode 
 
AFM can operate in different imaging modes that depend on the 
region of the force field between tip and sample as schematically shown 
in Figure 4.4. 
“Contact mode” has been the first imaging mode developed in 
AFM where the cantilever is placed few Ångstrom far from the sample 
surface [199]. During the scanning, the tip is constantly in contact with 
the sample, and the repulsive interaction forces (i.e. Coulomb forces) 
determine the cantilever deflection. The cantilever deflection is 
proportional to the topographical variations of the sample surface [217]. 
In contact mode AFM can be operated in either height or deflection 
mode. When operated in height mode, the system monitors the changes 
in piezo-vertical position, producing an accurate three-dimensional 
image also called "topography" image of the sample surface. 
When operated in deflection mode, the z-piezo remains stationary, 
while the deflection data, determined by the movement of the laser on 
the photodetector in response to topographical changes, are recorded to 
form sample surface. The resulting images are called "deflection" or 
"error signal" images. Images produced in error signal do not give 
quantitative information in the z-direction, but often are very useful for 
direct imaging of the small corrugations on the sample surface. Contact 
mode can operate in air, but the ambient humidity is sufficient to create a 
thin water layer on sample surface causing capillary forces between tip 
and sample. 
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Figure 4.4. Diagram illustrating the force regimes under which the most common 
AFM imaging operate. 
 
The capillary forces are attractive forces (10
-8
N), which keep the 
tip in contact with the sample surface. Because of this effect, the control 
on applied pressures in AFM imaging performed in contact mode in air 
is limited, which is a problem especially with soft biological samples. 
The total force exerted by the tip on the sample can be reduced, 
operating under aqueous environment, even of one order of magnitude 
compared with air [218]. The imaging in solutions has become very 
popular because it is potentially less destructive to soft samples. Contact 
mode is typically used to obtain nanometre resolution images to flat, 
hard and stable samples, such as 2D protein crystals.  
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A drawback of the contact mode is the presence of strong lateral 
forces derived from the lateral movement of the tip in contact with the 
sample. This problem is particularly evident for the biological samples, 
which are easily damageable. To overcome this problem another mode 
of imaging, non-contact and intermittent modes, have been developed. 
The magnitude of the forces applied to the sample by the AFM tip can be 
further reduced by applying non-contact mode [219,220]. This mode 
operates by bringing a probe, which is vibrating at its resonant 
frequency, into the attractive force region (within 10nm to the sample). It 
does not come into physical contact with the surface, but is able to detect 
force gradients as it is raster scanned across the surface by either shifts in 
the resonant frequency or amplitude of the cantilever.  
Non-contact mode is desirable as it allows to investigate the 
sample topography with a complete lack of sample damage. However, 
the long range attractive forces that operate between the sample and 
probe are relatively low and less sensitive to probe-sample separation as 
such, images obtained from this imaging mode inevitably display a 
lower spatial resolution. A reduction of lateral forces can be achieved 
imaging the sample using intermittent or tapping mode [221]. 
Tapping mode allow to study soft materials as biological 
samples. It uses an oscillating cantilever at its resonance frequency, 
placed near the sample surface, and only at the end of each oscillation 
cycle the tip interacts with the surface. Because the tip is not 
continuously in contact with the surface, both tip and sample 
degradations are minimized.  
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While the tip is moved towards the surface, a feedback system 
constantly adjusts the z-piezo to maintain the amplitude of the freely 
oscillating probe as a constant pre-set value [222]. The measured vertical 
displacements allow high resolution topography images of the sample 
surface to be reconstructed. The main advantage of this mode, as 
compared to the contact mode, is that lateral forces and friction are 
reduced. Hence, the oscillation mode is particularly convenient for AFM 
imaging of soft and weakly sample, such as living cells, biological 
membranes, proteins and DNA, both in air and in solution [223-226]. 
 
3.3 Tools to detect lipid rafts 
 
In 2007, K. Jacobson, O. Mouritsen and R. Anderson published a 
review entitled ‘‘Lipid rafts: at a crossroad between cell biology and 
physics”. They stated that ‘‘. .  the physical tools to study biological 
membranes as a liquid in space and time are still being developed…and 
the development of new tools are needed to understand the dynamic 
heterogeneity of biological membranes. . .” [227]. Studying lipid rafts is 
challenging since they are too small and elusive to be resolved by 
techniques such as optical and fluorescence microscopy.  
Electron microscopy (EM) allows the ultra-high spatial resolution 
necessary for the investigation of membrane lateral heterogeneity at the 
nanoscale. Using immunogold-EM and colloidal gold particles linked to 
anti-GSL antibodies has been possible observed that GSLs form clusters 
at the cell surface [228,229].  
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This method allows, observing the distribution of colloidal gold 
particles, to estimate average lipid raft size and the total membrane area 
occupied by lipid rafts.  
On the other hand, this method requires sample manipulation, 
such as the use of organic solvents and/or chemical fixatives that do not 
allow to preserve the in situ localization of membrane lipids [230]. A 
freeze-fracture replica labeling method can overcome some of the 
disadvantages of conventional immuno-EM, allowing quantitative 
analysis of the distribution of membrane lipids at a nanometer scale. In 
this method, living cells without pretreatment are flash-frozen, later the 
fractured membrane is coated by a thin layer of carbon and platinum via 
vacuum evaporation, fixing the membrane components [231]. This 
method has allowed to observe the distribution of GM3 and GM1 into 
indipendent clusters (<100 nm diameter) at the cell surface [232]. EM, 
allowed the observation of nanometer-sized biological macromolecules, 
however, because the biological matter is transparent compared with an 
electron beam, the sample must be frozen and/or fixed to gain contrast 
prior to imaging.  
The use of these invasive treatments limit the possibility of 
applying this technique to study samples in physiological conditions as 
well as to study the dynamic processes. 
Today, high-resolution techniques that utilize fluorescent probes 
are available for studies of membrane heterogeneity in intact cells, 
allowing the study of small and elusive microdomains in vivo (Table 2) 
[82,233,234].  
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Some of these techniques are particularly appealing because of 
their capability to reveal the dynamics of membrane domains.  
 
Technique Primary observable(s) 
Fluorescence correlation 
spectroscopy (FCS) 
Translational mobility of 
fluorophore 
Fluorescence renonance energy 
transfer (FRET) 
Donor-acceptor proximity 
Stimulated emission depletion 
(STED) microscopy 
Time traces of single molecule 
diffusion of a fluorescence-
labeled probe at the nano-scale 
 
Table 2. High-resolution techniques for detecting and characterizing membrane 
microdomains. 
 
The basic idea behind Stimulated Emission Depletion (STED) 
microscopy is the spatially selective deactivation of fluorophores, 
preventing their participation in image formation. Briefly, a laser beam 
that excites fluorescence, that is, which switches fluorescence ON, is 
focused onto a small (diffraction-limited) spot.  
Scanning this spot over the sample and detecting the fluorescence 
for each scanning position permits the reconstruction of an image by 
providing the spatial distribution of the fluorescent-labeled molecules. 
The addition of a second laser beam that switches off the fluorescence 
emission permits the observation of spots of nanoscopic size [235, 236].  
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This technique can be applied to investigate the ultrastructural 
organization of living cells, for example, for to test the lipid raft 
hypothesis.  
The Eggeling laboratory, using STED microscopy, showed for 
the first time a non-invasive imaging of lipid molecules and proteins 
with high spatial resolution within the membrane in live cells. In 
particular, they have demonstrated that lipid raft markers, such as GPI-
anchored proteins, SM, and GM1, were confined into membrane areas 
with diameters about 20nm. These complexes were transient and had an 
average lifespan about 10
-2
sec. The complexes appeared to be Chol-
dependent, as the trapping was reduced upon Chol depletion [134,237]. 
Photoactivated Localization Microscopy (PALM) is another 
powerful approach for investigating protein/lipid organization. 
Combining pair-correlation analysis with PALM provided a method to 
analyze complex patterns of protein organization across the plasma 
membrane demonstrating a distinct nanoscale organization of plasma 
membrane proteins with different membrane anchoring and lipid 
partitioning characteristics in COS-7 cells as well as dramatic changes in 
GPI-anchored protein arrangement under varying perturbations 
[238,239].  
Moreover, PALM imaging proved that Chol- and SL-enriched 
microdomains occupy different regions on the plasma membrane with 
lateral dimensions in the order of a hundred of nanometers [240]. In the 
super-resolution fluorescence microscopy, the major limitation is the 
necessity of using fluorescent probes or fluorescence-tagged antibodies 
against the target molecule, with the problems related to the use of 
probes, such as the generation of artifacts e.g., the multivalency of the 
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probe (as in the case of anti-glycolipid antibodies, which are usually 
IgM), chemical modifications introduced in the marker molecule, or the 
use of an extrinsic label [127]. 
 
3.3.1 AFM to study lipid rafts 
 
In the past decade, the AFM has emerged as a powerful tool to 
obtain nano-structural details and biomechanical properties (such as 
stiffness and viscoelasticity) of soft and fragile materials such as proteins 
and lipids, which is more challenging because of the easy deformability 
of the samples. AFM is unique in that it allows to study biological 
structures, using buffer solutions, in order to study functional complexes, 
to monitor their dynamic changes and to understand the range of 
conformations underlying different functions. Compared with Scanning 
Electron Microscopy (SEM), AFM provides extraordinary topographic 
contrast, direct height measurements and, not requiring a metal coating 
of the sample, in situ views of surface features. AFM has some 
advantages also on Transmission Electron Microscopy (TEM), 
principally the capability to obtain three dimensional images without 
cumbersome sample preparation and to yield far more complete 
information than the two dimensional profiles available from cross-
sectioned samples. AFM operating in physiological-like conditions and 
providing nanometer spatial resolution without fixation, staining, or 
labeling, appears to be a powerful tool to quantitatively perform a 
morpho-dimensional characterization of lipid rafts [241]. AFM has been 
employed to study structure and dynamics of lipid rafts based on model 
membranes [109,242,243]. 
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Rinia et al., used AFM to study supported lipid bilayers, 
consisting of PE, SM and Chol. They observed domains which the 
morphology and size depended on the cholesterol concentration.  
Moreover, they showed the resistance of domains against non-
ionic detergent. This study shows that it is possible to directly visualize 
SM/cholesterol domains and their resistance to detergent using AFM, 
illustrating the usefulness of this technique in raft studies [244]. 
Moreover, the change, at the nanometer level, of the lipid rafts in model 
membranes treated with Triton X-100 has been observed by Real-time 
AFM. This work indicates that AFM is a unique tool to investigate the 
structure of biological membranes in situ [245]. 
The Le Grimellec laboratory have studied the interactions 
between GPI-anchored alkaline phosphatases (AP-GPI) and rafts models 
using AFM. Their data showed that AP-GPI molecules inserted in 
membrane models can be easily imaged by AFM, in physiological 
buffer. In particular, they have observed that AP-GPI were generally 
observed in the most ordered domains of model membranes under phase 
separation, (i.e. presenting both fluid and ordered domains). This direct 
access to the membrane structure at a mesoscopic scale provides direct 
evidence for the temperature-dependent distribution of a GPI protein 
between fluid and ordered membrane domains. Moreover, these data 
strongly suggest that, within a membrane, subclasses of different GPI 
proteins can colocalize in subsets of microdomains enriched in 
sphingolipids and cholesterol [246]. 
The use of AFM to study membrane microdomains in supported 
planar lipid bilayers (SLB) is extensively described in a recent review by 
[247]. 
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Recently,  Cai et al., [248] have directly confirmed the existence 
of lipid rafts in native erythrocyte membranes using in situ atomic force 
microscopy. Their results indicate that most of the lipid rafts have lateral 
dimension in the order of hundred nm with irregular shape.  
Moreover, the Chol content contributes significantly to the 
formation and stability of the protein domains. Finally Band III is an 
important protein of lipid rafts in the inner leaflet of erythrocyte 
membranes, indicating that lipid rafts are exactly the functional domains 
in plasma membrane. This work provides evidence of the presence of 
lipid rafts at a resolution of a few nanometers, which will might open the 
way for studying their structure and functions in detail. 
However, AFM studies on whole cell are much more difficult to 
execute. In particular, intact membranes often contain numerous 
structures, many of which may be indistinguishable by AFM. It is 
difficult to obtain well-flattened and fixed plasma membrane samples as 
required to achieve the highest possible resolution in AFM. Furthermore, 
cell surfaces are covered by a cellular matrix consisting of proteins, 
proteoglycans, making direct access to the lipid surface difficult. 
Nonetheless, the application of AFM to live cells is holds promise.
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This chapter is based on: Corsetto PA, Cremona A, Montorfano G, 
Jovenitti IE, Orsini F, Arosio P, Rizzo AM. (2012) Chemical-physical 
changes in cell membrane microdomains of breast cancer cells after 
omega-3 PUFA incorporation. Cell Biochem Biophys. 64(1):45-59. 
 
4.1 Introduction 
 
Breast cancer is one of the most common cancers and the leading 
cause of death from cancer among women worldwide. The dietary habit 
plays an important role in the etiology of breast cancer. Indeed, for the 
past few decades, epidemiologic studies have suggested a relationship 
between dietary lipids and development/progression of cancer [1]. 
PUFAs are grouped into two main families, n-6 and n-3, distinguished 
on the position of the first double bond closest to the methyl end. The 
main dietary sources of Eicosapentaenoic (EPA, 20:5n-3) and 
Docosahexaenoic acid (DHA, 22:6n-3) are cold-water fish oils. There 
are in vitro and in vivo evidences that the administration DHA and EPA 
is able to reduce cancer proliferation and to increase apoptosis [2,3] as 
well as inhibit angiogenesis and metastasis, and to influence cancer 
differentiation [4,5]. A number of mechanisms have been proposed for 
the anticancer actions of n-3 PUFAs, including suppression of neoplastic 
transformation, inhibition of cell proliferation, enhancement of 
apoptosis, and antiangiogenic action. Numerous experimental data 
indicate that the presence of PUFAs in the membrane bilayer seem to 
involve changes in cell membrane fatty acid composition. 
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 n-3 PUFAs incorporated into membrane PLs can potentially 
affect a variety of plasma membrane physical properties including 
membrane thickness, fluidity, elasticity, permeability, the structure and 
function of membrane microdomains (lipid rafts) and alterations of cell 
signaling pathways that lead to altered transcription factor activity and 
changes in gene expression [6]. In fact the structure and dynamics of 
these polyunsaturated chains at the molecular level are profoundly 
different from their saturated counterpart, with very short reorientational 
correlation times and extremely low chain order. Moreover, much 
attention has been given to how DHA can alter membrane properties 
[7,8] and the organization and composition of membrane microdomains 
[6,9-11]. 
Lipid rafts are heterogeneous microdomains enriched in Chol, 
SM, saturated PLs. These microdomains are characterized 
physicochemically by a relative rigidity and reduced fluidity compared 
with the surrounding plasma membrane, which is in part caused by their 
Chol content [12,13]. Lipid rafts are highly dynamic and may rapidly 
assemble and disassemble, leading to a dynamic segregation of proteins 
[12-14]. In fact raft localization is shown to modulate a variety of 
proteins, such as receptor activities and therefore signal transduction 
[15,16]. Chol alterations, which affect on raft structure, also might alter 
the receptor function [15].  
In the present work, we treated breast cancer cells with DHA to 
assess if they are incorporated in membrane microdomain PLs and are 
able to change chemical and physical properties of these structures.  
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We analyzed the incorporation of PUFAs in cancer cell DRMs by 
High Performance Liquid Chromatography/Evaporative Light Scattering 
Detector (HPLC/ELSD) and Gas Chromatography (GC) analyses of raft 
phospholipid fatty acid composition. In addition, morpho-dimensional 
changes in DRMs have been visualized and evaluated by AFM studying 
purified membrane samples both before and after the n-3 PUFA 
treatment. 
Here I will concentrate on the effect of DHA incorporation in 
MDA-MB-231 breast cancer cell DRM microdomains. 
 
4.2 Material and methods 
 
Materials 
DHA (cis-4,7,10,13,16,19-docosahexaenoic acid sodium salt) was 
purchased from Sigma-Aldrich (St Louis, MO, USA). In order to prevent 
oxidation, DHA was dissolved in absolute ethanol, stocked under 
nitrogen, and stored at −80°C. The rabbit polyclonal anti-flotillin-1, the 
mouse monoclonal anti-clathrin heavy chain (HC) were purchased from 
Santa Cruz Biotechnology Inc. (CA, USA). Bound primary antibodies 
were visualized by the proper secondary horseradish peroxidase (HRP)-
linked antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, CA, 
USA) and immunoreactivity was assessed by chemiluminescence (ECL, 
PerkinElmer,USA). 
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Cell Lines and Culture Conditions 
Human breast cancer cells MDA-MB-231 (ER-negative and over-
expressing EGFR), derived from human mammary adenocarcinoma, 
were obtained from the IST (Italian National Cancer Research Institute, 
Genoa Italy, laboratory of Molecular Mutagenesis and DNA repair). The 
MDA-MB-231 cell line is routinely maintained in DMEM medium 
(Gibco-BRL, Life Technologies Italia srl, Italy) supplemented with 10% 
fetal bovine serum (FBS), 100U/ml penicillin, 100mg/ml streptomycin 
and 2mM glutamine. Cells were grown at 37°C in a 5% CO2 atmosphere 
with 98% relative humidity.  
 
Cell Viability Assay 
The DHA exposure effects on the cell viability were determined 
by a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay [17]. A tetrazolium salt has been used to develop a 
quantitative colorimetric assay for mammalian cell survival and 
proliferation. Yellow MTT is reduced to purple formazan in the 
mitochondria only when mitochondrial reductase enzymes are active, 
and therefore conversion can be directly related to the number of living 
cells. When the amount of purple formazan produced by cells treated 
with an agent is compared with the amount of formazan produced by 
untreated cells, the effectiveness of the agent in causing death of cells 
can be deduced, through the production of a dose-response curve. The 
absorbance of this colored solution can be quantified by measuring at a 
certain wavelength (usually between 500 and 600nm) by a 
spectrophotometer.  
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The main advantages of the colorimetric assay are its rapidly and 
precision, and the lack of any radioisotope. In details, cells were seeded 
and cultured in 96-well plates at 37°C to allow adhesion to the plate and 
to reach 50-60% confluence. After 48h, the medium was replaced with 
the experimental medium supplemented with DHA and incubated for 
further 72h. We have studied the effects of different DHA increasing 
concentrations dissolved in ethanol (50-300μM). The final concentration 
of ethanol was less than 1% in the culture medium, and it had no anti-
proliferative effect on MDA-MB-231 breast cancer cell line. After 
incubation, cells were incubated with 10μl of MTT stock solution 
(5mg/ml in PBS, pH 7.5) for 4 h at 37°C. For solubilization of the 
resultant formazan product, 100μl of solubilizing solution (10% v/v 
sodium dodecyl sulphate and 0.01M HCl) were added to each well and 
incubated overnight in a humidified incubator at 37°C. The absorbance 
of the color product was measured using a microplate reader at 540nm. 
Data represent the mean of eight values and results are expressed as 
Relative Growth Rate (RGR) in comparison with controls that were 
exposed to a concentration of ethanol equal to that in the samples 
exposed to fatty acids. All the reagents are purchased from Sigma-
Aldrich, USA. 
 
Detergent-Resistant Membranes (DRMs) isolation  
Data obtained from MTT assay on MDA-MB-231 cells have 
allowed to determine the concentration of DHA (200μM) required to 
inhibit cell growth by 20–30%. During treatments the MDA-MB-231 
cell line was seeded 1.5x10
4
 cells/cm
2
 for 48h.  
Chapter 4: Chemical-physical changes in cell membrane microdomains 
of breast cancer cells after DHA incorporation  
 
113 
 
After this period, fresh medium for treatments (DMEM + 10% 
FBS) containing DHA (200µM) was added, and the cells were further 
incubated for 72h without medium replacement. Experiments include 
control cells, which were not exposed to any exogenous fatty acids but 
incubated in the same conditions with the same ethanol concentration of 
treated cells. After treatment cells were washed two times with ice-cold 
phosphate-buffered saline (PBS), and then harvested by scrapering in 
PBS containing 0.4mM Na3VO4. Cells were centrifuged and lysed in 
1.4ml ice-cold lysis buffer (10mM Tris buffer, pH 7.5, 150mM NaCl, 
5mM EDTA, 1mM Na3VO4, 1mM phenylmethylsulfonyl fluoride, 
75milliunits/ml aprotinin) containing 1% Triton X-100 for 20min on ice. 
Lysates were thoroughly homogenized by a tight-fitting dounce 
homogenizer (10 strokes tight). The cell lysate was centrifuged at 1300g 
for 5min at 4°C, and the postnuclear supernatant (PNS) was transferred 
to an Eppendorf tube. 1ml of PNS was mixed in ultracentrifuge tubes 
(Beckman Coulter) with 1ml of ice-cold 85% (w/v) sucrose in TNEV 
(10mM Tris buffer, pH 7.5, 150mM NaCl, 5mM EDTA, and 1mM 
Na3VO4) and then overlaid with 5.5ml of 30% and 4ml 5% (w/v) sucrose 
in TNEV. The gradient was centrifuged with a TST-41.14 rotor at 4°C 
for 17h at 200,000g (Beckman Coulter Optima LE-80K Ultracentrifuge, 
Palo Alto, CA). Different fractions (1ml/fraction) were collected 
sequentially from the top of the gradient (fraction 1) to the bottom 
(fraction 11). DRMs were collected in low-density fractions (fractions 5 
and 6) corresponding to the 5% and 30% sucrose interface. 
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Lipid Extraction 
Fractionated cell membranes were extracted with three different 
chloroform/methanol mixtures (1:1, 1:2 and 2:1, v/v) and partitioned 
with the theoretical upper phase (TUP, chloroform/methanol/water, 
47:48:1, by volume) and then with water. The organic phase, after 
partitioning, was dried and then suspended in chloroform/methanol (2:1, 
v/v) for the analysis of PLs, Chol and gangliosides content. 
 
Characterization of DRMs  
Free Chol and SM were separated by HP-TLC using silice gel 
HP-TLC plates (Merck, Darmstadt, Germany). Chromatography was 
performed in hexane/ether/glacial acetic acid (90:10:1 by volume) and 
with chloroform/methanol/glacial acetic acid/water (60:45:4:2 by 
volume), respectively. Chol was visualized with a solution of copper 
sulfate in phosphoric acid at 180°C, while SM with anisaldehyde in 
acetic acid and sulfuric acid at 120°C. Chol and SM standards were 
spotted on the same plate to built a calibration curve. Quantitative 
analysis was performed by scanning densitometry. Known amounts of 
cholesterol standard, in four different increasing concentrations, were co-
chromatographed to obtain a calibration curve. While polar 
glycosphingolipids, contained in the upper phase, were always separated 
by HP-TLC using silice gel plates. Chromatography was performed in 
chloroform/methanol/0.25% aqueous CaCl2 (5:4:1 v/v/v). Plates were air 
dried and gangliosides visualized with resorcinol at 120°C. Ganglioside 
standards were spotted on the same plate. 
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For protein characterization of DRMs, all fractions were 
separated on SDS-PAGE (10% polyacrylamide gel) and incubated with 
different antibodies to raft (flotillin-1) and non-raft (clathrin HC) 
markers [18]. In particular, equal volumes of all fractions were re-
suspended in SDS loading buffer and boiled at 100°C for 5min to avoid 
to protein aggregates. Protein contents were quantified by Lowry assay 
[19]. Samples were separated by SDS-PAGE and transferred onto a 
PVDF membrane with Bio-rad Transfer Blot Apparatus at 150mA 
overnight at 4°C in a transfer buffer (25mM TrisHCl, 190mM glicine, 
20% methanol and 0.05% SDS) and analyzed by WB with anti-flotillin-1 
and anti-clathrin HC antibodies. Following transfer, the membrane were 
first blocked in blocking buffer consisting of 5% (w/v) dried non-fat 
milk in Tris-buffered saline (T-TBS: 10mM Tris/HCl, pH 7.5, 150mM 
NaCl, 0.1% (v/v) Tween®20) at room temperature for 1h. The blots 
were treated with anti-flotillin-1 primary antibody diluted 1:200 in 
blocking buffer at room temperature for 2h, washed 6 times (5 minutes 
each) with T-TBS and incubated with the proper horseradish peroxidase 
(HRP)-linked secondary antibody in blocking buffer at room temperature 
for 1h. After 6 washes (5 minutes each) with T-TBS, the protein bands 
were visualized using enhanced chemiluminescence (ECL) reagents 
(PerkinElmer, USA). Afterward, the same membranes was successively 
reblotted with the antibody specifically directed to clathrin HC. Briefly, 
the membranes were blocked in blocking buffer containing 5% dried 
non-fat milk in T-TBS at room temperature for 1h.  
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The blots were treated with anti-clathrin HC primary antibody 
diluted 1:1800 in blocking buffer at room temperature for 2h, washed 
with T-TBS and, then, incubated with the proper horseradish peroxidase 
(HRP)-linked secondary antibody in blocking buffer at room temperature 
for 1h. The protein bands were visualized using ECL reagents 
(PerkinElmer, USA).  
 
Analysis of Different Classes of DRM PLs and Chol 
Purification and quantitative analysis of membrane phospholipids 
and cholesterol was obtained using a HPLC-ELSD system (Jasco, Japan; 
Sedex SEDERE, FR) equipped with one pump, a SCL-10 Advp, a 
degasser module and a Rheodyne manual injector with 20μl sample loop 
and a column (length 250mm, I.D 4.6mm and film thickness 5μm) 
packed with silica normal-phase LiChrospher Si 60 (LiChroCART 250-
4, Merck, Darmstadt, Germany). The chromatographic separation is 
carried out as reported in literature [2]. In particular, the separation was 
achieved with a linear binary gradient of 0:100% to 100:0% (eluent B:A) 
in 14 min and then 100% B for 9min. Eluent A and B consists of 
chloroform/methanol/water 80:19.5:0.5 and 60:34:6 (v/v/v) respectively. 
The flow rate of the eluent was 1.0 ml/min. Total chromatographic run 
time was 40min per sample: 23min analysis, 12min to restore initial 
conditions and 5min to re-equilibration. Evaporative Light Scattering 
Detector Sedex (ELSD model 75, S.E.D.E.R.E., Alfortville, France) was 
used to detect and quantify separated PL species, in comparison with 
calibration standard curves.  
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The pressure of nebulizer gas (air) was maintained at 2.2 bar and 
the drift tube temperature was set at 50°C. After elution, samples are 
splitted in two aliquots. The ratio is 1:9, i.e., one part to the detector and 
nine parts were collected by Gilson Fraction Collector Model 201, in 
order to separate the different PL classes for further GC analysis. After 
separation, each PL class was analysed for fatty acid composition by GC 
in following conditions. Fatty acid methyl esters were obtained by 
transesterification with sodium methoxide in methanol 3.33 % w/v and 
injected into Agilent (Agilent Technologies 6850 Series II) gas 
chromatograph, equipped with a flame ionization detector (FID) and a 
capillary column (AT Silar; length 30m, film thickness 0.25μm). Helium 
was used as carrier gas with flow rate of 5.0ml/min, the injector 
temperature was 250°C, the detector temperature was 275°C, the oven 
temperature was set at 50°C for 20 min and then increased to 200°C at 
10°C min
-1
 for 20 min. Eptadecanoic acid methylester (Sigma-Aldrich, 
St. Louis, MO, USA) was utilized as internal standard. 
 
AFM imaging 
AFM is able to collect 3D topography images with high lateral 
and vertical resolutions, in the order of nanometre, without any sample 
preparation such as fixation or staining. In addition, AFM can work 
under near-physiological conditions, the only requirement being that the 
sample is well-flattened and adhered to a flat support. In fact, samples 
that have been flattened and tightly fixed to a substrate are required to 
obtain the highest possible resolution in AFM images.  
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For these reasons a freshly cleaved mica leaf was chosen as 
sample support because of its ultra-flat surface and simple preparation 
that did not require any chemical treatment to improve the sample 
adhesion. 
AFM imaging has been performed in collaboration with the 
laboratory of Prof. A. Lascialfari Department of Physics, Università 
degli Studi di Milano (Italy). Purified membrane samples obtained by 
the ultracentrifugation process, described above, were diluted 1:30 in a 
adsorption buffer (150mM KCl, 25mM MgCl2, 10mM Tris/HCl pH 7.5). 
50μl of the suspension is floated on a freshly cleaved mica leaf and let 
adhered for 10 min. Then, sample is gently rinsed 3 times with a 
recording buffer (150mM KCl, 10mM Tris/HCl pH 7.5) to remove 
membranes that have not been strongly adsorbed to the mica support. 
AFM imaging is performed in liquid buffer using a Multimode 
Nanoscope IIId (Veeco, Santa Barbara, CA, USA) equipped with a 12 
µm scanner and sharpened Si3N4 cantilevers with a constant spring of 
0.06N/m and a 10nm curvature radius (Veeco, Santa Barbara, CA, 
USA). The AFM is operated in Contact mode in constant force 
conditions. The set point is manually adjusted and kept as low as 
possible to obtain the best resolution while the total force applied on the 
sample during the imaging is approximately 300pN as measured by 
force–distance curve. The 512x512 pixel images are recorded at typical 
scan frequencies of 4–6Hz. AFM images are flattened using the SPMLab 
NT Ver. 6.0. software (Veeco, Santa Barbara, CA, USA). 
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Statistical analysis 
The data are presented as mean ± SD. Student’s t-test was used 
for comparisons between treated and control cells and the level of 
statistical significance was set at *p<0.05 and **p<0.01.  
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4.3 Results 
 
Numerous studies have demonstrated that DHA is capable of 
inhibiting proliferation through various mechanisms in vitro cultures of 
cancer cells [20]. To evaluate the effects of DHA on cell growth, MDA-
MB-231 breast cancer cells, were incubated for 72h in medium 
supplemented with various concentrations of DHA in the range 50-
300μM. The effects on cell viability were assessed and quantified by the 
MTT assay.  
As illustrated in Figure 1, DHA induces a dose-dependent 
reduction of cell viability at concentrations >200μM. In particular, at 
200μM of DHA we can observe a statistically significant decrease 
(**p<0.01) versus control groups of about 30% in cell growth with DHA 
supplementation. From these experiments, we extrapolated the dose to 
be used in the experiments to assess DHA incorporation into cell 
membrane PLs: 200μM which correspond to ~70% of viability of MDA-
MB-231 cell line.  
We first tested the purity of DRMs isolated from MDA-MB-231 
human breast cancer cells using lipid and protein raft and non-raft 
markers. In particular, biochemical analysis of the distribution of some 
lipids highly present in lipid rafts, namely Chol, Sm and ganglioside 
(GM1), carried out by HP-TLC confirmed the presence of the DRMs in 
the 5 and 6 fractions (Figure 2).  
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Figure 1. Effect of  DHA treatment on cell viability of MDA-MB-231 cells.  
The effects of DHA on cell growth inhibition were assessed and quantified by MTT assay. 
Cells were treated with various concentrations of DHA. Cells were seeded and cultured in 
a 96-well plate, after 48h, the medium was replaced with fresh medium supplemented with 
various concentrations of DHA (50-300μM) for further 72h. Data (mean ± DS; n = 8) are 
expressed as Relative Growth Rate (RGR) compared to the controls (100%), (**p<0.01).  
 
Moreover, specific antibody directed to raft marker, flotillin-1, 
was used to identified raft-enriched fractions, observing that this marker 
was mostly present in fraction 5 (Figure 2). The same membranes were 
then used to reblot with antibody directed to clathrin HC, a protein 
highly represented in non-raft fractions of plasma membrane [18], 
observing that this antibody recognized some bands especially in 
fraction 11 (Figure 2).  
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Figure 2. Lipid and protein characterization of DRMs.  
Each fraction were analyzed by western blot (top) of a raft protein (flotillin-1) and non raft 
protein (clathrin) markers, and by HP-TLC (bottom) of SM, Chol and ganglioside GM1. 
(a) control cells and (b) treated with DHA. 
 
Subsequently, we have evaluated the effects of DHA treatment on 
DRM structure and function. To determine the effects of exogenously 
added DHA on DRMs composition, the fractions were isolated from 
untreated and treated cells with DHA. After DRMs isolation we 
analyzed by GC PL fatty acid of DRMs fraction obtained from both 
treated and untreated cells. Even if no radiolabel compounds were used, 
we calculated the percentage of DHA incorporated into cell lipids.  
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Total fatty acid composition of DRM microdomains changes in 
DHA-treated cells compared to the untreated cells, as shown in Table 1. 
In particular, the treatment with DHA causes a significant increase of 
C22:6 n-3 (DHA) from 0.54 ± 0.29% to 6.66 ± 0.69% (mean ± SD; n = 
10), and of C20:5 n-3 (EPA) from 0.74 ± 0.35% to 1.49 ± 0.18% (mean 
± SD; n = 10). At the same time, the results show a reduction of C20:4 n-
6 (AA) from 4.29 ± 1.23% to 2.47 ± 0.38% (mean ± SD; n = 10). The 
observed differences between the DHA-treated and untreated DRM 
microdomains was statistically significant (**p<0.01). It is worth noting 
that the percentage of Saturated Fatty Acids (SFA) about 70% was not 
changed by DHA treatment. These data demonstrated that DHA is 
incorporated in cell membrane microdomains and is able to alter fatty 
acid composition without decreasing the total percentage of SFA that 
characterize these structures. In particular, DHA determines an increase 
of n-3 PUFA and a decrease of n-6 PUFA. 
To detect if DHA treatment induces specific changes in fatty acid 
composition of DRM microdomain phospholipids, we have carried out a 
study using a HPLC-ELSD system. In particular, membrane PLs and 
Chol have been purified and analyzed by HPLC-ELSD system.  
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 CTR DHA 
C16:0 42.63 ± 3.04 44.88 ± 0.12 
C16:1 3.07 ± 1.45 5.00 ± 1.09* 
C18:0 33.85 ± 3.96 26.70 ± 6.61 
C18:1 10.75 ± 3.55 7.56 ± 2.01 
C18:2 (LA) 2.24 ± 0.89 2.49 ± 1.98 
C18:3 (ALA) 0.72 ± 0.29 1.93 ± 0.35** 
C20:3 0.61 ± 0.18 0.25 ± 0.04** 
C20:4 (AA) 4.29 ± 1.23 2.47 ± 0.38** 
C20:5 (EPA) 0.74 ± 0.35 1.49 ± 0.18** 
C22:5 (DPA) 0.33 ± 0.15 0.56 ± 0.06* 
C22:6 (DHA) 0.54 ± 0.29 6.66 ± 0.69** 
SFA 76.48 ± 6.95 71.58 ± 6.69 
MUFA 13.82 ± 4.77 12.56 ± 3.06 
n-3 PUFA 2.34 ± 0.94 10.64 ± 1.27** 
n-6 PUFA 7.15 ± 1.91 5.22 ± 2.39 
 
Table 2. FA composition of DRMs purified from DHA-treated and untreated cells.   
Data (mean ± SD; n = 10) are expressed as % of FAs, *p<0.05; **p<0.01. MUFA: 
Monounsaturated Fatty Acids; SFA: Saturated Fatty Acids.  
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The DHA incubation determines its incorporation in all PLs, 
except in PS, in MDA-MB-231 microdomains, as shown in Figure 3. In 
particular, DHA improves in PE from 1.99 ± 0.64% to 8.61 ± 1.34% 
(mean ± SD), in PI from 0.88 ± 0.05% to 9.94 ± 2.08% (mean ± SD), in 
PC from 0.6 ± 0.15% to 10.41 ± 1.99% (mean ± SD), and in SM from 
0.3 ± 0.12% to 2.47 ± 0.14% (mean ± SD). At the same time, the results 
show a reduction of AA from 15.28 ± 3.46% to 5.38 ± 1.54% (mean ± 
SD) in PE and from 6.27 ± 0.82% to 2.17 ± 0.29% (mean ± SD) in PI. 
Moreover, DHA causes a significant increase of EPA from 0.46 ± 0.19% 
to 0.79 ± 0.13% (mean ± SD) in PE, from 0.8 ± 0.51% to 13.16 ± 3.48% 
(mean ± SD) in PI, from 0.35 ± 0.34% to 1.8 ± 0.21% (mean ± SD) in 
PC, and from 0.89 ± 0.35% to 3.78 ± 0.26%  (mean ± SD) in SM. The 
observed differences between the DHA-treated and untreated DRM 
microdomains were statistically significant (*p<0.05; **p<0.01). 
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Figure 3. Histogram of DRM phospholipid polyunsaturated fatty acid composition of 
DHA-treated and untreated cells.  
Values (mean ± SD; n = 15 and 6 untreated and DHA-treated cells respectively) are 
expressed as percentage of total fatty acids. Asterisks indicate significant differences 
between treated and control cells, *p<0.05; **p<0.01. 
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We can conclude that our data demonstrated that DHA is 
incorporated in breast cancer membrane microdomains with different 
specificity for the PLs moiety. Moreover, we have evaluated the effects 
of these incorporations on Chol and SM relative content in DRM 
microdomains. Collected data indicate that n-3 PUFA treatment modifies 
the content of SM. As show histogram reported in Figure 4, the DHA 
treatment shows a significant reduction (**p<0.01) of SM content about 
40% (from 244.22 to 162.35 nmol/mg proteins) in DRMs compared to 
the control.  
 
 
 
Figure 4 Effects of n-3 PUFAs on SM relative content in DRM. 
MDA-MB-231 cells fractionated on sucrose gradient has been analysed by HPLC-ELSD. 
Cells were treated with DHA for 72h. Measurements were performed in triplicate and data 
are presented as percentage of control ± SD (n = 3), **p<0.01. 
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Cholesterol is known to play a key role in maintaining membrane 
integrity, signal transduction and fluidity. Moreover, cholesterol is a 
important component of lipid rafts [21]. For these reasons, we have also 
carried out a study to evaluate the effects of n-3 PUFA treatment on 
Chol content in microdomains. The data indicate that DHA determines a 
remarkable and significant reduction  (*p<0.05) of this sterol. As shown 
in the histogram reported in Figure 5, DHA determines a reduction of 
Chol content about 70% content in DRMs (from 829.39 to 585.62 
nmol/mg proteins) compared to the control.  
 
 
 
Figure 5. Effects of n-3 PUFAs on Chol relative content in DRM microdomains. 
MDA-MB-231 cells fractionated on sucrose gradient has been analysed by HPLC-ELSD. 
Cells were treated with DHA for 72h. Measurements were performed in triplicate and data 
are presented as percentage of control ± SD (n = 3), *p<0.05. 
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Previously results obtained by AFM analysis were relative to 
DRMs isolated from estrogen-sensible human cancer cell, MCF-7. In 
particular, AFM investigation allowed to relate chemical–physical 
modifications, induced in breast cancer membrane microdomains by the 
DHA incubation, to their morpho-dimensional changes. AFM images 
were collected in a saline liquid buffer operating in Contact mode and in 
constant force conditions. Figure 6, as an example, shows two AFM 
topography images of MCF-7 DRMs before (a) and after (b) DHA 
incorporation. In particular, AFM imaging shows membrane patches 
with lateral size in the order, on average, of a few microns. After DHA 
incubation, AFM images clearly show a reduction of the number of 
membrane patches (in the order of about 20–30%). Moreover, DHA 
treated DRMs show, on average, a lateral size larger than the control 
ones. In addition, interestingly the profile lines (see Figure 6) show the 
presence, in the DHA incorporated rafts, of two different height ranges, 
4–4.5nm and 6–6.5nm. In particular, the 6 nm thickness of membrane 
patches could be produced by DHA incorporation effects. On the 
contrary, untreated samples show a constant height of about 4nm as 
awaited for a membrane lipid bilayer. 
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Figure 5. AFM topography images collected in contact mode in buffer solution of 
MCF-7 DRMs before (a) and after (b) treatment with DHA. For all the images: 
Vertical scale (from darkest to lightest): 50nm; scan area: 10x10 µm. 
 
 
 
Figure 6. Height profiles corresponding to the two black lines drawn in the AFM 
topography images reported in Figure 5. (a) control sample, (b) DHA-treated sample. 
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4.4 Discussion 
 
Our study was aimed to understand if the n-3 PUFA effects on 
cancer cells may be related to alteration of biochemical and biophysical 
characteristics of DRMs.  
There are in vitro and in vivo evidences that the administration of 
EPA and DHA is able to reduce cancer proliferation and to increase 
apoptosis [2,3] as well as inhibit angiogenesis and metastasis, and to 
influence cancer differentiation [4,5]. The plasma membrane is involved 
in many aspects of cell biology, including proliferation, differentiation 
and apoptosis. Fatty acids in the PLs of cell membranes play a key role 
in maintaining the fluidity, structure and function of the cell membrane. 
Thus, changes in membrane PL fatty acid composition can influence the 
function of cells. In particular, n-3 PUFAs incorporated into membrane 
PLs can potentially affect a variety of plasma membrane physical 
properties including membrane thickness, fluidity, elasticity, 
permeability, cell signaling pathways, and the structure and function of 
membrane microdomains, known as lipid rafts [6,22,23]. 
 Lipid rafts are known to be rich in signalling proteins, such as 
Src, and tyrosin kinases receptors as EGFR, and to regulate signal 
transduction in normal and cancer cells [24,25]. The key difference 
between the lipid rafts and the surrounding membrane bilayers is their 
lipid composition. Rafts contain Chol and SLs at concentrations up to 
50% higher than rest of the membrane. Moreover, the hydrophobic alkyl 
chains of lipids within the rafts are more saturated compared to the 
surrounding bilayer and hence tightly packed [26-28].  
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In the present paper, we treated MDA-MB-231 cells with DHA in 
relative high concentration to assess if they were incorporated in 
membrane microdomain PLs and were able to change chemical and 
physical properties of these structures. We chosen relative high 
concentration of PUFA because in our condition the cells were relatively 
resistant to FA treatment. Moreover, the EPIC-Norfolk cohort study 
showed that the average concentration of DHA in plasma is 236.2μmol/l, 
with a high individual variability [29]. These data demonstrate that in 
vivo the doses used in our study can be reached and in some case are 
relative normal. 
Focusing on MDA-MB-231 breast cancer cells treated with DHA, 
our data demonstrate that DHA and its metabolites are inserted with 
different yield in cell membrane microdomains and are able to alter fatty 
acid composition without decreasing the total percentage of SFA that 
characterize these structures. We have also analyzed the changes in 
content of SM in DRMs. In particular, DHA treatment determines a 
reduction of SM content of about 40%. These reductions might be due to 
an activation of Sphingomyelinase (SMase). SMase is an enzyme that 
catalyzes the hydrolysis of SM to ceramide. A variety of studies has 
shown that the ceramide is ubiquitously produced during cellular stress 
and is associated with apoptosis [31,31]. The neutral SMase (N-SMase) 
is a plasma membrane-bound enzyme that is implicated in mediating 
apoptosis and it resides in lipid rafts [30]. Therefore, factors influencing 
the lipid composition of membranes can influence the activity and 
distribution of N-SMase in microdomains.  
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Wu et al., already demonstrated that in Jurkat leukemic cells, 
EPA and DHA increase the N-SMase activity inducing SM hydrolysis 
[32], our data are in agreement with these observations. Moreover, we 
also analyzed the changes in content of Chol of DRMs. Our results 
showed that DHA determines a reduction of Chol content of about 70%. 
Sterols are the major non-polar lipids of cell membranes, and Chol 
predominates in mammalian cell. The unique puckered four-ring 
structure of Chol confers special biophysical properties that increase the 
ordering (cohesion and packing) of neighbouring lipids. Because of the 
rigid sterol backbone, Chol is preferentially positioned in close 
proximity to saturated hydrocarbon chains of neighbouring lipids, as 
these are more inflexible and elongated compared with those of 
unsaturated lipids. It therefore plays a very important and dominant role 
in raft formation and stabilization [28,33,34].  
Cholesterol accumulation is known to be associated in many 
tumors, including prostate cancer and oral cancer [35,36], and 
dysregulated in lung and breast cancers [37,38]. Moreover, depletion of 
Chol results in the disorganization of DRMs microdomains and 
dissociation of proteins bound to the lipid rafts [9]. Grimm et al., 
recently demonstrated that treatment of SH-SY5Y cells with DHA 
displaces Chol from DRMs to “non-raft” detergent soluble membranes 
(DSMs) [39]. The laboratory of Chapkin, have evaluated the effects of n-
3 PUFA administration on Chol and SM content in lipid rafts in multiple 
cell types, such as immortalized young adult mouse colonocytes 
(YAMC) and mouse splenic T-cells.  
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Their results have showed a reduction of Chol (46%) and SM 
(30%) in YAMC and mouse splenic T-cells fed n-3 PUFAs, respectively 
[40]. Thus, our data are in agreement with these observations. 
Unfavorable interaction between Chol and PUFA chains has been clearly 
demonstrated by the exclusion of Chol from dipolyunsaturated PC 
liposomes where it is forced to directly contact polyunsaturated chains. 
Studies using a variety of techniques including Differential Scanning 
Calorimetry (DSC), 
2
H NMR spectroscopy, indicate of that the poor 
affinity of DHA for Chol provides a lipid-driven mechanism for lateral 
phase separation of cholesterol-rich lipid microdomains from the 
surrounding bulk membrane. This could in principle alter the size, 
stability and distribution of cell surface lipid microdomains such as rafts 
[22]. Since lipid rafts are predominantly enriched in saturated fatty 
acids-containing SLs and Chol, the incorporation of PUFA, especially 
DHA, determines a reorganization of membrane microdomains. In 
particular, different models have been proposed: Wassall and Stillwell 
hypothesized that the energetically less favorable interaction between 
Chol and DHA promotes lateral phase segregation into sterol-
poor/PUFA-rich and sterol-rich/saturated fatty acid-rich microdomains 
[41]. Moreover, Shaikh proposed the formation of ‘‘declustered rafts’’. 
His model shows that n-3 PUFAs disrupt the molecular organization of 
membrane microdomains by directly incorporating into the raft, shifting 
out the Chol into non-rafts domains with reorganization of lipids and 
proteins [42]. Finally, Chapkin and his lab have demonstrated that n-3 
PUFAs modify lipid raft organization, leading to altered cell signaling 
and function.  
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They have proposed a putative model for the effect of n-3 PUFAs 
on lipid rafts where n-3 PUFAs are incorporated into PLs which are 
inserted into both raft and non-raft regions of the plasma membrane. 
This results in a deplete of Chol and SM and a clustering of lipid raft 
regions. Moreover, many lipid raft associated proteins are relocated to 
the bulk membrane. This results in a suppression of lipid raft mediated 
processes, including the activation and downstream signal transduction 
[40].  
AFM imaging was useful to characterize morpho-dimensionally 
changes in DRMs studying purified membrane samples both before and 
after the DHA incorporation. In particular, preliminary data showed that, 
in breast cancer cells after DHA incorporated, membrane patches had 
two different height ranges, 4-4.5nm and 6-6.5nm (in the order of about 
20%). On the contrary, untreated samples showed a constant height of 
about 4 nm as awaited for a membrane lipid bilayer. Moreover, DHA-
treated samples show, a decrease the number of membrane patches in the 
order of about 20-30%, and, in on average, a lateral size larger than the 
control ones. These changes might influence resident protein 
conformation turning on and/or off signaling proteins, and modulate 
cellular events. In fact acyl moieties of proteins partition in the 
cytoplasmic leaflet of the membrane lipid bilayer. Lipid alterations in the 
cytoplasmic lipid leaflet of membrane rafts would hence be particularly 
effective in displacing palmitoylated proteins. 
 
 
 
Chapter 4: Chemical-physical changes in cell membrane microdomains 
of breast cancer cells after DHA incorporation  
 
136 
 
4.5 Conclusions 
 
Complex SLs and Chol are required to facilitate raft formation. 
Because of its polyunsaturation, DHA is sterically incompatible with 
SLs and Chol and, therefore, is believed to alter lipid raft behavior and 
protein function. Our results showed that n-3 PUFAs are able to modify 
membrane microdomain biochemical and biophysical features leading to 
decrease of breast cancer cell proliferation probably through different 
mechanisms related to acyl chain length and unsaturation. In particular, 
DHA may change the biophysical properties of lipid rafts decreasing the 
content of Chol and SM. We suggest that the alteration of microdomains 
lipid composition might determine the displacement of proteins, such as 
EGFR and Ras, from rafts in n-3 PUFA treated cells with alteration of 
signal transduction. Although caution is needed when drawing 
conclusions based solely on the capacity of detergent to solubilize lipids, 
collectively, these data support our hypothesis that n-3 PUFAs can alter 
specific lipid microdomains. 
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This chapter is based on: Cremona A, Orsini F, Arosio P, Corsetto PA, 
Montorfano G, Lascialfari A, Rizzo AM. (2012). Atomic force 
microscopy imaging of lipid rafts of human breast cancer cells. 
Biochim Biophys Acta. 1818(12):2943-9  
 
5.1 Introduction 
 
Accumulating evidence indicates that cell membrane constituents 
might be not randomly distributed but rather organized in small 
lipid/protein domains enriched in sphingomyelin (SM) and cholesterol 
(Chol), known as lipid rafts [1,2]. Lipid rafts are tiny, dynamic, and 
ordered microdomains, enriched in cholesterol and sphingolipids [3]. 
These domains are characterized physic-chemically by a relative rigidity 
and reduced fluidity compared with the surrounding plasma membrane, 
which is in part caused by their cholesterol content [4,5]. Moreover, they 
are highly dynamic and may rapidly assemble and disassemble, leading 
to a dynamic segregation of proteins [6]. Proof of the existence of lipid 
rafts is based largely on biochemical evidence even if the lipid raft 
hypothesis is still a contentious topic, with much of the scientific 
community divided. In particular, the inability to visualize lipid rafts 
directly in cell membranes, as well as a lack of understanding of some 
basic properties (e.g. size and lifetime), has led to controversy over their 
definition and existence.  
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The coexistence of domains in liquid-ordered (Lo) and liquid-
disordered (Ld) phases has been extensively characterized [7,8]. Studies 
of membrane model systems strongly suggest that lipids could laterally 
segregate in membranes under certain conditions, and could form 
distinct lipid domains with particular structural characteristics (i.e. a 
particular lipid phase). Self-associative properties unique to 
sphingolipids and Chol in vitro could facilitate selective lateral 
segregation in the membrane plane and serve as a basis for lipid sorting 
in vivo [1]. Studying lipid rafts is challenging since they are probably too 
small to be resolved by techniques such as optical and fluorescence 
microscopy. Today, high-resolution techniques that utilize fluorescent 
probes are available for studies of membrane heterogeneity in intact 
cells, allowing the study of small and elusive microdomains in vivo 
[9,10,11]. Some of these techniques are particularly appealing because of 
their capability to reveal the dynamics of membrane domains. For 
example, Stimulated-Emission-Depletion (STED) nanoscopy [12] 
provided direct evidence in live cells that certain lipids are transiently 
trapped in Chol-assisted molecular complexes. In particular, these 
studies have demonstrated that lipid raft markers, such as GPI-anchored 
proteins, SM, and GM1, were confined into membrane areas with 
diameters about 20nm. These complexes were transient and had an 
average lifespan about 10
-2
 sec. The complexes appeared to be 
cholesterol-dependent, as the trapping was reduced upon cholesterol 
depletion [9,13,14]. Photoactivated Localization Microscopy (PALM) is 
another powerful approach for investigating protein/lipid organization.  
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PALM imaging proved that Chol- and sphingolipid-enriched 
microdomains occupy different regions on the plasma membrane with 
lateral dimensions in the order of a hundred of nanometers [15]. In the 
past decade, Atomic force microscopy (AFM) has emerged as a 
powerful tool to obtain nano-structural details of soft and fragile 
materials such as proteins and lipids.  
AFM operating in physiological-like conditions and providing 
nanometer spatial resolution without fixation, staining, or labeling, 
appears to be a powerful tool to quantitatively perform a morpho-
dimensional characterization of lipid rafts [16]. Moreover, thanks to its 
high signal-to-noise ratio, AFM allows to monitor function related 
structural conformational changes and to observe structural details of 
membrane proteins under physiological conditions, revealing 
information on the protein oligomeric state and on the supramolecular 
architecture of membrane protein complexes [17,18]. 
In this work we applied AFM, together with biochemical assays, 
Western Blotting (WB) and High Performance Thin Layer 
Chromatography (HP-TLC), to the study of Detergent-Resistant 
Membranes (DRMs) of MDA-MB-231 human breast cancer cells. In 
particular, the different fractions, isolated in the purification process by 
ultracentrifugation on sucrose gradient, have been analyzed with respect 
to their protein content and morpho-dimensionally characterized.  
 
 
 
 
Chapter 5: Atomic ForceMmicroscopy imaging of lipid rafts of human breast cancer 
cells 
 
148 
 
5.2 Materials and methods 
 
Cell Lines and Culture Conditions 
See Chapter 4, section Materials and methods, for a detailed 
description of human breast cancer cells MDA-MB-231 and culture 
conditions 
 
DRMs Isolation  
See Chapter 4, section Materials and methods, for a detailed 
description of DRM isolation from MDA-MB-231 cells. 
 
Western blot analysis for flotillin-1 
All fractions were separated by SDS-PAGE (10% polyacrylamide 
gel) and transferred onto a polyvinylidene difluoride (PVDF) membrane 
overnight then blocked in blocking buffer consisting of 5% (w/v) dried 
non-fat milk in Tris-buffered saline (T-TBS: 10mM Tris/HCl, pH 7.5, 
150mM NaCl, 0.1% (v/v) Tween®20) at room temperature for 1h. The 
blots were treated with anti-flotillin-1 primary antibodies diluted 1:200 
in blocking buffer at room temperature for 2h, washed with T-TBS and 
incubated with the proper secondary antibody in blocking buffer at room 
temperature for 1h. The protein bands were visualized using ECL 
reagents (PerkinElmer, USA). 
 
Lipid composition analysis 
See Chapter 4, section Materials and methods, for a detailed 
description of DRM lipid composition analyses. 
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AFM imaging 
See Chapter 4, section Materials and methods, for a detailed 
description of AFM imaging conditions. AFM imaging has been 
performed in collaboration with the laboratory of Prof. A. Lascialfari 
Department of Physics, Università degli Studi di Milano (Italy).  
 
Sample preparation protocol for AFM imaging  
See Chapter 4, section Materials and methods, for a detailed 
description of the purified membrane sample preparation protocol for 
AFM imaging. 
 
AFM-immunolabeling and analysis procedures 
Membrane samples, adsorbed onto mica surface and prepared as 
above described, were incubated with different antibodies such as to raft 
marker as rabbit polyclonal anti flotillin-1 antibodies raised against 
amino acids 324–427 of flotillin-1, a protein segment near the C-
terminus and fully exposed in the cytoplasmic side of the plasma 
membrane, and non-raft marker such as anti-clathrin hc mouse 
monoclonal antibody raised against the N-terminus of clathrin heavy 
chain of human origin (Santa Cruz Biotechnology, USA).  
The antibodies were diluted 1:4 in recording buffer as reported in 
literature [19] and the sample was imaged prior and after 60min to assess 
the antibody binding, allowing the direct comparison of the same 
membrane patches before and after antibody binding. We have evaluated 
the difference of the surface area both, before and after the antibodies 
incubation, as follows.  
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The contour line of a number of membrane patches as well as of 
microdomains protruding from the patch surface were marked before 
and after 60min treatment with anti flotillin-1 and anti-clathrin hc 
antibodies directly from several AFM images using the ImageJ 1.45 
software (NIH, USA). 
 
Statistical analysis 
The data are presented as mean ± SD (or SE). Student’s t-test was 
used for comparisons between treated and control cells and the level of 
statistical significance was set at *p<0.01.  
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5.3 Results 
 
In the present work, lipid rafts were isolated from MDA-MB-231 
human breast cancer cells as DRMs by ultracentrifugation on a 
discontinuous sucrose gradient as described in details in Materials and 
Methods. We have applied biochemical assays WB and HP-TLC, 
together with AFM, to characterize the DRMs of MDA-MB-231 cells.  
As reported in Chapter 4 “Chemical-physical changes in cell 
membrane microdomains of breast cancer cells after omega-3 PUFA 
incorporation”, the purity of isolated DRMs was demonstrated using 
lipid and protein raft and non-raft markers. In particular, biochemical 
analysis of the distribution of some lipids highly present in lipid rafts, 
namely Chol, Sm and ganglioside (GM1), carried out by HP-TLC 
confirmed the presence of the DRMs in the 5 and 6 fractions.  
The presence of DRMs was verified detecting in all the 11 
collected fractions the raft and non-raft protein marker, flotillin-1 and 
clathrin HC, respectively [20] by SDS-PAGE assay and WB analysis. 
In particular, as shown in Figure 1, WB analysis showed that in 
the low-density fractions (fractions 5 and 6), corresponding to the 5% 
and 30% sucrose interface, are enriched of flotillin-1 and depleted of 
clathrin HC indicating that these fractions are enriched with DRMs  
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Figure 1. Distribution of flotillin-1 and clathrin HC in DRMs.  
Triton X-100 lysates of cell cultures were purified and fractionated by sucrose gradient 
ultracentrifugation. Equal volumes of each fraction were analyzed by WB using anti-
flotillin-1 and anti-clathrin HC antibodies.  
 
In order to perform a morpho-dimensional characterization of 
DRMs, all the 11 fractions purified in the ultracentrifugation process 
were visualized by AFM. AFM images were collected in a saline liquid 
buffer operating in tapping mode. Tapping mode can reduce significantly 
the lateral forces, allowing to study samples too fragile to withstand the 
lateral forces of Contact mode as biological samples. 
 It uses an oscillating cantilever at its resonance frequency, placed 
a few nanometers above the sample surface, and only at the end of each 
oscillation cycle the tip interacts with the surface. Because the tip is not 
continuously in contact with the surface, the sample degradations are 
minimized.  
Figure 2 shows AFM topography images of some among the 11 
fractions isolated and visualized in a saline buffer. Depending on the 
fractions visualized, the situation dramatically changes. In particular, 
AFM imaging of fractions 5 and 6 shows the higher number of 
membrane patches, which decreases moving from fractions 5 to 7.  
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Moreover, only small membrane fragments with lateral 
dimensions of a few dozen of nanometers are visualized on the mica 
support in fractions from 1 to 4, 8 and 9. Fractions 10 and 11 show a 
continuous and homogeneous distribution of membrane fragments on the 
whole mica surface. It is worth noting that these fractions are recovered 
at the bottom of the tube exactly where the post-nuclear supernatant 
(PNS) is placed before the ultracentrifugation process.  
 
 
 
Figure 2. AFM topography images of some isolated fractions.  
Purified membranes were diluted 1:30 in adsorbtion buffer and placed on a mica support. 
For all the images: scan area: 10×10μm; vertical scale: 20nm (see insert in Fig.).  
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Taken together, the biochemical analyses and AFM imaging 
indicate that DRMs are mainly present in the low-density fractions 
(fractions 5 and 6).  For these reasons a detail AFM study of  these 
fractions have been performed. As an example, an AFM topography 
image of membrane samples prepared from fraction 5 is reported in 
Figure 3. 
 
 
 
Figure 3. AFM topography image of membrane samples collected in liquid buffer in 
tapping mode (a). (b) Height profile corresponding to the white line drawn in (a). Scan 
area: 2.5×2.5μm; vertical scale: 9nm (see insert in Fig. 2).  
 
Different regions can be easily identified in Figure 3: the mica 
support, membrane patches and microdomains protruding from the 
membrane surface.  Analyzing several AFM topography images 
collected in tapping mode in buffer solution we have morpho-
dimensionally characterized the structures visualized in Figure 3a.  
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In particular, the membrane patches showed lateral size in the 
order, on average, of a few microns and height of about 4 nm, as awaited 
for lipid bilayers. Moreover, the microdomains, protruding by 1-2nm 
from the surrounding membrane as shown in the height profile reported 
in Figure 3b, exhibited lateral dimensions in the range of 100–500nm, in 
agreement with the data obtained using artificial membranes [21].  
The brighter areas visible on membrane patches could be 
identified as protein aggregates probably produced during the sample 
deposition process and induced by the interactions with the mica 
support.  
Microdomains have a highest surface roughness compared to the 
surrounding membrane that appears very smooth. Surface roughness of 
membrane patches as well as of the membrane microdomains, expressed 
as differences in the root-mean-square of the vertical Z dimension values 
within the examined areas, was calculated according to the following 
equation: 
 
 
where Zaverage is the average Z value within the examined area, 
Zx,y is the local Z value and N indicates the number of points within the 
area. 
Rms surface roughness values were calculated as the mean of at 
least 15 measurements on 50 × 50nm square areas collected on the 
surface of membrane patches and membrane microdomains observed in 
several AFM topography images.  
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In particular, the microdomain has a mean rms surface roughness 
of 0.26 ± 0.03nm (mean ± SD; n = 18), while the surrounding membrane 
is very smooth with a mean rms surface roughness of only 
0.11 ± 0.01nm (mean ± SD; n = 15).  
The microdomains visualized on the membrane patch surface 
appear to be very interesting since their dimensions are in line with the 
range expected for lipid rafts as reported extensively in literature [22,23]. 
For this reason we also performed a high resolution AFM 
imaging of these areas aiming at obtaining more detailed insights. 
 
 
 
Figure 4. High resolution AFM topography image.  
AFM image of a membrane sample prepared from fraction 5 collected in liquid buffer in 
tapping mode (left). Height profile corresponding to the black line drawn in AFM image 
(right). Scan area=200×200nm; vertical scale: 9nm (see insert in Fig. 2). 
 
In particular, the AFM image obtained by scanning an area of a 
few hundred square nanometers and reported in Figure 4, shows a 
microdomain protruding by about 1nm from the membrane surface (red 
arrows). Moreover, the height profile (see Figure 4 right) shows some 
structural features on the microdomain surface with heights of about 
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1nm and lateral sizes of a few nanometers, thus suggesting the presence 
of proteins embedded in the microdomain.  
Unfortunately these nanometer structures cannot be identified, but  
their structural features appear to be in good agreement with the 
dimensions of proteins observed by AFM on biological membranes [24]. 
In order to obtain more information regarding the nature of the 
microdomains we incubated at room temperature the purified membrane 
samples adsorbed onto mica with specific antibody against a lipid raft 
protein marker, flotillin-1. In particular, rabbit polyclonal antibodies 
raised against amino acids 324–427 of flotillin-1, a protein segment near 
the C-terminus and fully exposed in the cytoplasmic side of the plasma 
membrane were injected into the AFM liquid cell. The sample was 
visualized before and after 60min to assess the antibody binding, 
allowing the direct comparison of the same membrane patches before 
and after antibody binding. As shown in Figure 5, the microdomains 
visualized after the antibody incubation changed in their dimensions and 
shape (see circled areas in Figure 5a and b). In particular, microdomains 
protruding from the smooth lipid membrane increased their surface area 
by about 20% upon antibody binding. We found a surface area increase 
of 22.3 ± 4.9% (mean ± SD; n = 25) and 9.3 ± 2.3% (mean ± SD; n = 25) 
for microdomains and membrane patches respectively as indicated in the 
histogram in Figure 5c.  
The observed difference among the surface area increase of the 
microdomains, induced by the anti-flotillin-1 treatment, and of 
membrane patches both in the anti-flotillin-1 treated and control 
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experiment as well as of the microdomains in the control experiment is 
statistically significant (*p<0.01). 
 
 
 
Figure 5. AFM-immunolabeling.  
AFM topography images of membrane samples prepared from fraction 5 and collected in 
liquid buffer in tapping mode at room temperature. Membrane patches (a) were incubated 
with anti-flotillin-1 antibody for different times. Just after 60min of treatment (b) the 
surface area of microdomains clearly increases (see circled areas). Scan area: 5×5μm; 
vertical scale: 9nm (see insert in Fig. 2). (c) Histogram of the surface area increase for 
membrane patches and microdomains, after 60min anti-flotillin-1 antibody incubation 
(blue bars) and of the surface area increase for membrane patches, and microdomains in 
the control experiment after 60min anti-clathrin hc antibody incubation (red bars). Asterisk 
indicates significant differences between room and physiological temperature (*p<0.01).  
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To demonstrate specificity and get rid of possible physisorption 
phenomena, we carried out experiments using non-rafts marker antibody. 
In particular, membrane samples were incubated with antibodies raised 
against a non raft protein marker, clathrin hc, [25] as described in 
Material and methods. After 60min incubation with anti-clathrin hc 
antibody, microdomains did not show significant variation in shape and 
lateral dimensions. In particular, after anti-clathrin hc incubation, surface 
area increases of 8.1 ± 1.6% (mean ± SD; n = 10) and 9.4 ± 2.5% (mean 
± SD; n = 10) for microdomains and membrane patches, respectively 
(see histogram reported in Figure 5c). However, the difference between 
the surface area increase of microdomains and membrane patches in 
these experiments was not statistically significant. The experimental data 
suggest that the protein nature of the visualized nanometer structures and 
confirm the presence of flotillin-1, a protein marker of lipid rafts, in the 
membrane microdomains. 
Moreover, although the enlargement of the microdomain surface 
area is the more evident effect visible in AFM images (see Figure 5), it 
is expected that antibody binding should also result in an increase of 
height and surface corrugation of the microdomains [26]. The analysis of 
the height profiles derived from cross-sections perpendicular to the 
microdomain long axis and obtained by AFM topography images 
collected before and after the anti flotillin-1 treatment made difficult to 
quantify a reliable difference even if the experimental data showed a 
slight increase of the microdomain height and the height profiles 
exhibited a higher corrugation after the antibody binding.  
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Quantitative information was obtained by the analysis of the rms 
surface roughness. In particular, the rms surface roughness of the 
membrane microdomains, measured on 50×50nm square areas, increased 
from 0.25 ± 0.03nm (mean ± SD; n = 11) to 0.34 ± 0.03nm (mean ± SD; 
n = 11) after the antibody binding. 
 
5.4 Discussion 
 
AFM has been shown to be a very useful technique to visualize 
and quantitatively characterize the topology of biological membranes 
also in physiological-like conditions [24,27]. Moreover, AFM has been 
employed to study structure and dynamics of lipid rafts based on ternary 
lipid mixtures commonly used to mimic membrane rafts [28] and, more 
recently, also in native membranes [29].  
In the present study we applied Tapping mode AFM imaging, 
coupled with WB and HP-TLC to obtain a biochemical characterization 
of the structures visualized in AFM images, to characterize lipid rafts 
extract as Detergent-Resistant Membranes (DRMs) of MDA-MB-231 
human breast cancer cells.  
Membrane patches of MDA-MB-231 cell resistant to Triton X-
100 extraction were purified by ultracentrifugation on a discontinuous 
sucrose gradient. All the 11 isolated fractions were analyzed with respect 
to raft lipid (Chol and SM) and protein (flotillin-1) marker. The 
biochemical data therefore confirm a larger presence of lipid rafts 
marker in the low-density fractions 5 and 6 corresponding to the 5% and 
30% sucrose interface.  
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In agreement with biochemical analyses, AFM imaging 
visualized large and planar membrane patches with lateral sizes of a few 
microns and a height of about 4–5nm, as awaited for single lipid 
bilayers, only in the fractions with the richest content of flotillin-1, Chol 
and SM (Fig. 2). Moreover, the number of the membrane patches 
decreases from fractions 5 to 7 as well as the flotillin-1, Chol and SM 
content. 
The standard method of isolation of membrane rafts involves 
solubilization of the membrane at 4°C using the non-ionic detergent, 
typically Triton X-100. Thank to their low relative density, due to of 
their high lipid-to-protein ratio, membrane rafts are separated by 
centrifugation on discontinuous or continuous sucrose gradients. Usually 
DRMs are isolated in the low-density fractions corresponding to the 5% 
and 30% sucrose interface [30]. Although Triton X-100 is the best 
characterized and most widely used detergent for DRMs purification, 
some observations raised the hypothesis that treatment of cells with 
detergents may generate clusters of raft lipids and proteins that did not 
exist in the intact cells [31]. 
AFM imaging of samples prepared from fractions 5 and 6 showed 
many membrane patches with lateral dimension in the order of 1–3μm 
that may be formed through a mechanism of coalescence as a result of 
detergent treatment. However, a recent study demonstrated that Triton 
X-100 does not induce domain formation or increase the fraction of the 
bilayer in the ordered state,although it does increase domain size by 
coalescing pre-existing domains [32]. Thus our observations are in 
agreement with this theory. 
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It is worth noting that, high resolution AFM imaging of samples 
prepared from fraction 5 showed microdomains that protruding by 1–
2nm from the membrane patches, with lateral dimensions in the range of 
100–500nm in line with the data obtained using model membranes to 
study lipid rafts [21]. Moreover, the microdomains exhibit a surface 
corrugation (surface roughness = 0.26 ± 0.03nm; mean ± SD, n = 18) 
with nanometer features on its surface which resemble proteins in both 
size and shape. The AFM-immunolabeling with anti flotillin-1 antibody 
showed that the microdomains changed their size and appearance 
showing an evident enlargement of the surface area (about 20%), and a 
higher surface corrugation after the antibody binding. On the contrary, 
control experiments carried out using anti clathrin hc, a non specific 
antibody raised against a non raft protein marker [25], did not show a 
statistically significant variation of surface area of microdomains (Fig. 
5). It is worth noting that the increase of the surface area of the 
membrane microdomains induced by the anti flotillin-1 treatment 
showed values distributed in two different ranges, 8–10% and 24–27%. 
These differences can be justified taken in account that the sample 
preparation protocol for AFM imaging does not allow to select the 
orientation of the membrane patches on the mica support. Since anti 
flotillin-1 binds to the cytoplasmic side of the plasma membrane, the 8–
10% surface area increase could be induced by non specific 
physisorption phenomena on microdomains exposing the external face of 
the membrane. As a result the increase of the micro-domain surface area 
of about 20% induced by the anti flotillin-1 antibody binding could be an 
underestimation of the real value. 
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5.5 Conclusions 
 
Taken together the biochemical data as well as the flotillin-1 
recognition and its high content in the membrane microdomains, 
strongly indicate that the nanometer areas protruding from the membrane 
patch surface and visualized in AFM images could be identified as lipid 
rafts. As a final comment, it is worth speculating on the utility of 
nanoscale methods, such as AFM, for probing raft domains in cells. In 
this context, our results on the presence of flotillin-1 and their co-
localization with membrane microdomains is an important step toward 
the direct visualization of lipid and protein components of rafts in native 
membranes. 
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This chapter is based on: Reversible dissolution of microdomains in 
native plasma membranes at physiological temperature (article in 
preparation). Data have been obtained during my Erasmus placement 
in the laboratory of Dr. B.W. Hoogenboom London Centre for 
Nanotechnology, University College London (UK). 
 
6.1 Introduction 
 
A typical membrane is overwhelmingly complex, contains 
hundreds of lipid species, such as glycerophospholipids (GPLs), 
sphingolipids (SLs) and cholesterol (Chol), that differ in their physico-
chemical properties, lipophilic molecules and membrane proteins in two 
asymmetric leaflets [1]. It is becoming increasingly apparent that such a 
complex assortment of lipids is necessary to accomplish the manifold 
functions that lipids perform. Thanks to electron microscopy (EM) 
images, S.J. Singer and G.L. Nicolson proposed the model to "fluid 
mosaic" of biological membranes [2]. This model assigned to the lipid 
bilayer a certain degree of fluidity. In fact, at physiological temperature, 
the fatty acyl chains of the phospholipids (PLs) of the lipid bilayer are in 
a fluid phase. Thus, the cellular membrane appear to be a two-
dimensional solutions of integral membrane proteins in a lipid bilayer 
solvent [3], allowing the lateral movement of membrane components. As 
a consequence of the lipid bilayer fluidity, the membrane components 
can create “membrane domains” that differ in lipid and/or protein 
composition from that of the surrounding lipid matrix [4]. 
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Such bilayer domains, also called “lipid rafts”, are known to be 
dynamic, small and ordered domains enriched in Chol, SM and specific 
proteins that may formed  into larger structures due to lipid–lipid, lipid–
protein, and protein–protein interactions [5]. The organization of 
membranes into dynamic platforms serves to bring about a functional 
compartmentalization so that multimolecular interactions, such as 
membrane trafficking, signal transduction, and regulation of the activity 
of membrane proteins, can be executed and regulated in space and time 
[6]. Under physiological conditions, lipid bilayers exist in a liquid 
disordered (Ld) phase, upon cooling below the melting point, the lipid 
acyl chains are frozen in an solid-ordered phase (So) where their 
mobility is restricted. However, because of the high concentration of 
Chol in the plasma membrane, a third physical phase, the liquid ordered 
(Lo) phase, can be observed. In the Lo state, acyl chains of lipids are 
extended and tightly packed. In this sense, the Lo state is similar to the 
gel state, and lipids that favor gel state formation, and thus have a high 
melting temperature (Tm) in the absence of Chol, tend to form the Lo 
state in the presence of Chol. On the other hand, lateral diffusion in the 
Lo state appears to be almost as rapid as in the fluid Ld state [7]. 
The “lipid rafts” structure appears to arise from the phase 
separation of a Ld/Lo phase. The coexistence of domains in Lo and Ld 
phases has been extensively characterized. Studies of membrane model 
systems using a variety of techniques, such as Fluorescence Resonance 
Energy Transfer (FRET), Deuterium-based Nuclear Magnetic Resonance 
(
2
H-NMR) and Atomic Force Microcopy (AFM) strongly suggest that 
lipids could laterally segregate into macroscopic (>200nm) or 
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microscopic (<100nm) membrane domains under certain conditions [8]. 
Model systems have greatly improved our understanding of the structure 
and function of cell membranes, but the model membranes don’t reflect 
the complexity of the lipid environment or the interactions between 
lipids and proteins in a cell membrane. 
Giant plasma membrane vesicles (GPMVs), microscopic spheres 
of plasma membranes harvested from live cells following chemical 
treatment [9] are probably the closest models of cell plasma membranes 
in terms of chemical composition, as in addition to lipids they contain 
also membrane proteins.  Fluid phase separation has been reported in 
giant GPMVs obtained from mast cells and fibroblasts [10,11], from 
A431 [12] and RBL-2H3 [13] cells. Bernardino de la Serna et al., [14] 
using Fluorescence Microscopy (FM) and AFM under physiological 
conditions, observed the coexistence of two distinct micrometer sized 
fluid phases (ordered and disordered-like phases) in GPMVs obtained 
from native pulmonary surfactant membranes. Moreover, their results 
showed that the phase separation was dramatically affected by the 
extraction of Chol. Model membranes and GMPVs show clearly 
separated microscopic domains of Lo/Ld phases, while in cell plasma 
membranes these domains have not been really observed except in some 
rare exceptions [15,16], due to the complexity of cell membrane 
organization.  
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In the past decade, AFM has emerged as a powerful tool to obtain 
nano-structural details of soft and fragile materials such as proteins and 
lipids. AFM operating in physiological-like conditions and providing 
nanometer spatial resolution without fixation, staining, or labeling, 
appears to be a powerful tool to quantitatively perform a morpho-
dimensional characterization of membrane microdomains, such as 
Detergent-Resistant Membrane (DRM) microdomains [17-18].  
In this work we applied AFM to the study DRM microdomains of 
MDA-MB-231 human breast cancer cells. In particular, we carried out a 
study using a heating control system to obtain more information 
regarding the temperature-induced phase behavior on membrane 
microdomains resistant to non-ionic detergent (Triton X-100) extraction. 
 
6.2 Materials and methods  
 
Cell Lines and Culture Conditions 
See Chapter 4, section Materials and methods, for a detailed 
description of human breast cancer cells MDA-MB-231 and culture 
conditions 
 
DRMs Isolation  
See Chapter 4, section Materials and methods, for a detailed 
description of DRM isolation from MDA-MB-231 cells. 
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AFM imaging 
See Chapter 5, section Materials and methods, for a detailed 
description of AFM imaging conditions.  
AFM imaging has been performed in collaboration with the 
laboratory of Dr. B.W. Hoogenboom London Centre for 
Nanotechnology, University College London (UK). 
 
Sample preparation protocol for AFM imaging  
See Chapter 4, section Materials and methods, for a detailed 
description of the purified membrane sample preparation protocol for 
AFM imaging. 
 
Temperature-controlled AFM imaging 
AFM imaging was performed at different temperatures in liquid 
buffer using a Multimode Nanoscope IIIa (Bruker, Santa Barbara, CA, 
USA) equipped with a J piezo scanner (125x125μm) AS 130V and with 
a heating control system (Multimode AFM high temperature heater, 
Bruker, Santa Barbara, CA, USA) which allows to control the 
temperature in the range 25-250°C. Mica support was glued to a Teflon 
layer which in turn was glued to a metal disk that was magnetically fixed 
to the AFM sample holder. Basically, the temperature setup consists of a 
sample heater and a electronic heater controller that allows for setting a 
desired sample temperature.  
The sample heater is a ceramic block that carries an embedded 
micro-heater placed between the scanner and the sample that transmits 
the heat to the sample from underneath.  
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Although the distance between the heating element and the 
sample inside the buffer droplet is typically in the range of a few mm, 
there can be the problem of thermal gradients from the heater element to 
the mica support. To reduce this problem, before to observe the sample, 
we have evaluated the real temperature inside the AFM fluid cell. 
Briefly, using a control system we have measured the temperature inside 
the buffer droplet just in contact with the sample surface.  
Temperature-controlled experiments were performed with a 
temperature controller stage (Multimode AFM temperature heater 
controller with a range of 25-250°C, Bruker, Santa Barbara, CA, USA). 
In particular, membrane samples adsorbed onto the mica surface, as 
described above, were visualized changing the temperature over a large 
range (25-45°C). Moreover, once the desired temperature was reached, 
the system was allowed to thermally equilibrate for approximately 30sec 
before the tip approaching the sample surface. Starting from room 
temperature (~25°C), the temperature was incremented in 2°C steps till 
to ~40°C. Then, the sample was cooled back to room temperature to 
return to the initial conditions. AFM images were collected at different 
steps of temperature, for example, 25°C, 30°C, 37°C and 25°C (“thermal 
cycle”). AFM images were collected approximately every 10min 
allowing the direct comparison of the same membrane patches before 
and after the temperature increase.  
 
AFM-imunolabeling and analysis procedures 
See Chapter 5, section Materials and methods, for a detailed 
description of the purified membrane sample labeling and AFM imaging. 
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Statistical analysis 
The data are presented as mean ± SD (or SE). Student’s t-test was 
used for comparisons between treated and control cells and the level of 
statistical significance was set at *p< 0.01.  
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6.3 Results 
 
As reported in Chapter 4 “Chemical-physical changes in cell 
membrane microdomains of breast cancer cells after omega-3 PUFA 
incorporation”, the purity of isolated DRMs was demonstrated using 
lipid and protein raft and non-raft markers. In particular, biochemical 
analysis of the distribution of some lipids highly present in lipid rafts, 
namely Chol, Sm and ganglioside (GM1), carried out by HP-TLC 
confirmed the presence of the DRMs in the 5 and 6 fractions. Moreover, 
the same fractions, showed higher content of flotillin-1, a protein marker 
of lipid rafts, indicating that these fractions are enriched with DRMs. 
Moreover, as reported in Chapter 5 “Characterization of DRMs 
Microdomains from Human Breast Cancer Cells”, AFM imaging of the 
purified fractions enriched in DRMs, showed membrane microdomains 
with lateral dimensions of a few hundreds of nanometers. Moreover, 
treating the samples with a specific antibody against the protein flotillin-
1, an increase of the microdomain surface area occurs thus suggesting 
the presence of flotillin-1, a lipid raft-associated protein [19], in the 
visualized membrane microdomains.  
Starting from these results, we have decided to apply AFM to 
characterize the phase behavior of DRM microdomains. In particular, we 
carried out a study using a heating control system to elucidate the 
kinetics on the phase transition process. Briefly, AFM images were 
collected at different steps of temperature, for example, 25°C, 30°C, 
37°C and 25°C (“thermal cycle”).  
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This experiment allowed the direct comparison of the same 
membrane patches during the thermal cycle. As an example, an AFM 
topography image of thermal cycle collected in Tapping mode in buffer 
solution is reported in Figure 1. In particular membrane patches and 
microdomains protruding from their surface are clearly identified at 
25°C. As described in Chapter 5, the membrane patches showed lateral 
size in the order, on average, of a few microns and height of about 4nm, 
as awaited for lipid bilayers. While the microdomains, protruding by 1-
2nm from the surrounding membrane exhibited lateral dimensions in the 
range of 100–500nm, in agreement with the data obtained using artificial 
membranes [20]. Interestingly, when the temperature is increased (till 
37°C), the membrane patches are even visible on mica support, while, as 
clearly visible in Figure 1, the size and shape of the microdomains 
depend strongly on the temperature. In particular, when the temperature 
is increased (above 30°C) the smaller microdomains (less than 100nm in 
diameter) disappear while the larger microdomains are reduced in size. It 
is worth of notice that at physiological temperature (around 37°C), it is 
possible to see only a few and smaller microdomains which lateral 
dimensions, of the order of an tens of nanometers. 
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Figure 1. Reversible dissolution of microdomains at physiological temperature.  
AFM topography images of DRMs collected at different temperatures. For all AFM images 
Scan area: 3 × 3 μm; vertical scale: 9 nm (see insert in Fig.).  
 
In addition, when the sample was cooled back to room 
temperature, the microdomains become again visible on membrane patch 
surface even if they change in shape and size and/or position, thus 
suggesting a dynamic nature of these structure (Figure 1). 
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The quantitative analysis of AFM images corresponding at many 
thermal cycles allowed to calculate the total surface area of the 
microdomains at different temperature. In particular, Figure 2 shows the 
plot of microdomains surface area collected at different temperatures, 
obtained analyzing 8 thermal cycles, and normalized to the mean total 
area of microdomains collected at room temperature (25°C). In particular 
we found a decrease of the microdomains total surface area of 77.2 
± 1.9% and 96.7 ± 0.9% (mean ± SEM) at 30°C and 36°C respectively. 
The observed difference between the total surface area decrease of 
microdomains at 25°C and 36°C is statistically significant (*p<0.01).  
 
 
 
Figure 2. Microdomain area as a function of temperature. 
Scattering of the mean total surface area of microdomains at different temperatures. Data 
(mean ± SEM) have been obtained analyzing different thermal cycles ( n= 8). Total surface 
area at 25°C was used to normalized results. 
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Figure 3 shows the plot of microdomains height (measured with 
respect to the membrane patches surface) observed at different 
temperatures, obtained analyzing 8 thermal cycles. In particular, the 
microdomains protrude by about 1.5nm from the surrounding membrane 
at room temperature, while they show an height about 1nm in the range 
of physiological temperature.  
 
 
Figure 3. Microdomain height above the membrane as a function of temperature.  
Scattering of the mean height for microdomains at different temperatures. Data (mean ± 
ES) have been obtained analyzing different AFM images collected at different 
temperatures. 
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To verify that the microdomain size modifications were not 
induced by the mechanic effect produced by the AFM tip during the 
sample scanning, we have carried out a study at physiological 
temperature scanning the membrane patches after a long period of 
temperature stabilization. As shown in Figure 4, scanning the sample till 
to 180min changes in the microdomain dimensions do not occur. These 
results strongly indicate that the microdomain size is totally temperature 
dependent. 
Finally, in order to verify the presence, at room temperature, of 
proteins in reshaped DRMs after the thermal cycles treatment, we carried 
out a new study using anti-flotillin-1 antibody. The purified DRMs 
adsorbed onto mica were heated till to 40°C and then cooled back to the 
room temperature. Subsequently, the samples were incubated with anti-
flotillin-1 antibody (diluition 1:4) and imaged at room temperature after 
60min of treatment.  
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Figure 4. Membrane and microdomain stability at 37°C.  
AFM topography images of membrane samples prepared from fraction 5 and collected in 
liquid buffer in Tapping mode at same temperature (37°C) for long times. For all images 
scan area: 5 x 5µm; vertical scale: 9nm (see insert in Fig. 1). 
 
The reshaped microdomains after thermal cycle showed an 
enlargement of their surface area (about 25%). In particular, we found a 
surface area increase of 25.3 ± 6.3% (mean ± SD; n = 17) and 
9.2 ± 2.5% (mean ± SD; n = 15) for microdomains and membrane 
patches respectively as shown in the histogram in Figure 5. The 
observed difference between the surface area increase of membrane 
patches and microdomains after antibody incubation was statistically 
significant (*p<0.01). These data suggest the presence of flotillin-1 in 
the membrane microdomains after the thermal treatment.  
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Figure 5. AFM-imunolabeling. 
AFM topography images of membrane samples prepared from fraction 5 and collected in 
liquid buffer in tapping mode after the thermal cycle.  For all images scan area: 8 x 8µm; 
vertical scale: 9nm (see insert in Fig. 1). Membrane patches (a) were incubated with anti 
Flot-1 antibodies. After 60 min of treatment (b) the surface area of microdomains clearly 
increases. For all images scan area: 8 x 8 µm; vertical scale: 9nm (see insert in Fig. 1). (c) 
Histogram of the surface area increase after anti-flotillin-1 antibody incubation (*p<0.01). 
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6.4 Discussion 
 
A typical membrane is overwhelmingly complex, contains 
hundreds of lipids species that differ in their physico-chemical 
properties, lipophilic molecules and membrane proteins in two asym-
metric leaflets [1]. Such a multicomponent mixture exhibits a complex 
phase behavior. This phase behavior can modify the orientation and 
mobility of membrane lipids and proteins, and will therefore affect 
membrane functionality. At physiological temperatures, membranes are 
fluid, thus both, lipids and proteins can diffuse laterally within the 
membrane lipid bilayer plane, creating membrane domains with lipid 
and/or protein composition different from that of the surrounding lipid 
matrix [4]. 
The domain structure appears to arise from the phase separation 
of a Ld phase enriched in low melting temperature lipids, characterized 
by high fluidity in which the lipid acyl chains are disordered and highly 
mobile, and a Lo phase enriched in Chol and high melting temperature 
lipids such as SM [7].  
The forces that control the formation and dynamics of this 
membrane microdomains are not yet fully understood. Thus, the 
observation and the characterization of phase separation in purified 
plasma membranes becames important for better understand the lateral 
organization of microdomains within the plasma membrane.  
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In the past decade, AFM has emerged as a powerful tool to obtain 
nano-structural details of soft and fragile materials such as proteins and 
lipids. In particular, operating in physiological-like conditions and 
providing nanometer spatial resolution without fixation, staining, or 
labeling, AFM appears to be a powerful tool to quantitatively perform a 
morpho-dimensional characterization of membrane microdomains 
[18,21-23]. 
Taken together, the biochemical analyses and AFM imaging 
reported above (see Chapter 4 and 5) indicate that the DRMs (fractions 
5 and 6) were enriched with lipid and protein raft marker, such as Chol, 
SM and flotillin-1. Moreover, AFM imaging of these fractions, showed 
membrane lipid bilayers and microdomains with lateral dimensions in 
the range of 100–500nm that protrude of about 1-2nm from the 
membrane surface. For these reasons, the phase behavior, of the purified 
DRM microdomain, has been studied as a function of the temperature 
using an AFM equipped with a heating control system. Moreover, the 
use of isolated and purified membranes, in our case DRM purified by 
ultracentrifugation process, offers the possibility to observe nano-scale 
domains and small height differences by AFM, in order to study 
temperature effects without deregulating the whole cell. 
Our results show that, when the temperature is increased (till 
37°C), the membrane patches are even visible on mica support while, the 
surface area of the microdomains depend strongly on the temperature 
and were not induced by the mechanic effect produced by the AFM tip 
during the sample scanning.  
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In particular, when the temperature is increased the smaller 
microdomains (less than 100nm in diameter) disappear while the larger 
microdomains are reduced in size. Moreover, the height of 
microdomains is temperature dependent (Fig. 3). In addition, when the 
sample was cooled back to room temperature, the microdomains become 
again visible on membrane patch surface even if they change in shape 
and size and/or position, thus suggesting a dynamic nature of these 
structure. Take together these data suggest that the microdomains and 
their behavior as function of the temperature, appear to be in agreement 
with the phase separation of a Ld and Lo phase observed both, in model 
membrane and GPMVs [24].  
It is worth of notice that at physiological temperature, it is 
possible to see only a few and smaller microdomains which lateral 
dimensions, of the order of a tens of nanometers. These data suggest that 
these microdomains might exist in living cells, indeed their lateral 
dimension are in agreement with the range expected for membrane 
microdomains observed in living cell using a Stimulated Emission 
Depletion (STED) far-field fluorescence microscopy  [25]. 
Finally, we observed an enlargement of reshaped microdomains 
surface area after anti-flotillin-1 antibody incubation (Fig. 5). These data 
suggest the presence of flotillin-1 in the membrane microdomains after 
the thermal treatment, sustaining the dynamics of these structures and 
their ability to carry around proteins. Moreover, our findings 
demonstrate the high affinity of flotillin-1 proteins to the visualized 
microdomains. 
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6.5 Conclusions 
 
These preliminary results suggest that AFM could be an useful 
tool to study the phase coexistence of a Ld and Lo domain in purified  
plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6: Reversible dissolution of microdomains in native plasma membranes 
at physiological temperature 
 
189 
 
References 
1. van Meer G, Voelker DR, Feigenson GW: Membrane lipids: 
where they are and how they behave. Nature reviews 2008, 
9(2):112-124. 
2. Singer SJ, Nicolson GL: The fluid mosaic model of the 
structure of cell membranes. Science (New York, NY 1972, 
175(4023):720-731. 
3. Coskun U, Simons K: Membrane rafting: from apical sorting 
to phase segregation. FEBS letters 2010, 584(9):1685-1693. 
4. Sonnino S, Prinetti A: Membrane domains and the "lipid 
raft" concept. Current medicinal chemistry, 20(1):4-21. 
5. Kraft ML: Plasma membrane organization and function: 
moving past lipid rafts. Molecular biology of the cell 2013, 
24(18):2765-2768. 
6. Simons K, Gerl MJ: Revitalizing membrane rafts: new tools 
and insights. Nature reviews 2010, 11(10):688-699. 
7. Heberle FA, Feigenson GW: Phase separation in lipid 
membranes. Cold Spring Harbor perspectives in biology 2011, 
3(4): a004630. 
8. Hancock JF: Lipid rafts: contentious only from simplistic 
standpoints. Nature reviews 2006, 7(6):456-462. 
9. Scott RE: Plasma membrane vesiculation: a new technique 
for isolation of plasma membranes. Science 1976 ,194:743–
745. 
10. Baumgart T, Hammond AT, Sengupta P, Hess ST, Holowka 
DA, Baird BA, Webb WW: Large-scale fluid/fluid phase 
Chapter 6: Reversible dissolution of microdomains in native plasma membranes 
at physiological temperature 
 
190 
 
separation of proteins and lipids in giant plasma membrane 
vesicles. Proceedings of the National Academy of Sciences of 
the United States of America 2007, 104(9):3165-3170. 
11. Veatch SL, Cicuta P, Sengupta P, Honerkamp-Smith A, 
Holowka D, Baird B: Critical fluctuations in plasma 
membrane vesicles. ACS chemical biology 2008, 3(5):287-293. 
12. Lingwood D, Ries J, Schwille P, Simons K: Plasma 
membranes are poised for activation of raft phase 
coalescence at physiological temperature. Proceedings of the 
National Academy of Sciences of the United States of America 
2008, 105(29):10005-10010. 
13. Sezgin E, Levental I, Grzybek M, Schwarzmann G, Mueller V, 
Honigmann A, Belov VN, Eggeling C, Coskun U, Simons K et 
al: Partitioning, diffusion, and ligand binding of raft lipid 
analogs in model and cellular plasma membranes. 
Biochimica et biophysica acta 2012, 1818(7):1777-1784. 
14. Bernardino de la Serna J, Perez-Gil J, Simonsen AC, Bagatolli 
LA: Cholesterol rules: direct observation of the coexistence 
of two fluid phases in native pulmonary surfactant 
membranes at physiological temperatures. The Journal of 
biological chemistry 2004, 279(39):40715-40722. 
15. Gaus K, Gratton E, Kable EP, Jones AS, Gelissen I, Kritharides 
L, Jessup W: Visualizing lipid structure and raft domains in 
living cells with two-photon microscopy. Proceedings of the 
National Academy of Sciences of the United States of America 
2003, 100(26):15554-15559. 
Chapter 6: Reversible dissolution of microdomains in native plasma membranes 
at physiological temperature 
 
191 
 
16. Gousset K, Wolkers WF, Tsvetkova NM, Oliver AE, Field CL, 
Walker NJ, Crowe JH, Tablin F: Evidence for a physiological 
role for membrane rafts in human platelets. Journal of 
cellular physiology 2002, 190(1):117-128. 
17. Anderton CR, Lou K, Weber PK, Hutcheon ID, Kraft ML: 
Correlated AFM and NanoSIMS imaging to probe 
cholesterol-induced changes in phase behavior and non-
ideal mixing in ternary lipid membranes. Biochimica et 
biophysica acta 2011, 808(1):307-315. 
18. Orsini F, Cremona A, Arosio P, Corsetto PA, Montorfano G, 
Lascialfari A, Rizzo AM: Atomic force microscopy imaging 
of lipid rafts of human breast cancer cells. Biochimica et 
biophysica acta 2012, 1818(12):2943-2949. 
19. Pike LJ: Lipid rafts: bringing order to chaos. Journal of lipid 
research 2003, 44(4):655-667. 
20. Rinia HA, Snel MM, van der Eerden JP, de Kruijff B: 
Visualizing detergent resistant domains in model 
membranes with atomic force microscopy. FEBS letters 
2001, 501(1):92-96. 
21. Connell SD, Smith DA: The atomic force microscope as a 
tool for studying phase separation in lipid membranes. 
Molecular membrane biology 2006, 23(1):17-28. 
22. El Kirat K, Morandat S: Cholesterol modulation of 
membrane resistance to Triton X-100 explored by atomic 
force microscopy. Biochimica et biophysica acta 2007, 
1768(9):2300-2309. 
Chapter 6: Reversible dissolution of microdomains in native plasma membranes 
at physiological temperature 
 
192 
 
23. Cai M, Zhao W, Shang X, Jiang J, Ji H, Tang Z, Wang H: 
Direct evidence of lipid rafts by in situ atomic force 
microscopy. Small 2012, 8(8):1243-1250. 
24. Risselada HJ, Marrink SJ: The molecular face of lipid rafts in 
model membranes. Proceedings of the National Academy of 
Sciences of the United States of America 2008, 105(45):17367-
17372. 
25. Eggeling C, Ringemann C, Medda R, Schwarzmann G, 
Sandhoff K, Polyakova S, Belov VN, Hein B, von Middendorff 
C, Schonle A et al: Direct observation of the nanoscale 
dynamics of membrane lipids in a living cell. Nature 2009, 
457(7233):1159-1162. 
  
Chapter 7 
DHA alters membrane 
microdomain  organization and 
EGFR-related signaling in MDA-
MB-231 breast cancer cells  
Chapter 7: DHA alters membrane microdomain  organization and EGFR-
related signaling in MDA-MB-231 breast cancer cells 
 
194 
 
This chapter is based on: DHA alters membrane microdomain  
organization and EGFR-related signaling in MDA-MB-231 breast 
cancer cells (article in preparation). 
 
7.1 Introduction  
 
Lipid rafts are defined as small, dynamic, ordered domains of 
Chol, SLs, and specific proteins that may combine into larger structures 
due to lipid–lipid, lipid–protein, and protein–protein interactions [1]. 
Moreover, they can include or exclude proteins, for this reason, they may 
be involved in a wide variety of cellular functions and biological events 
[2,3] such as signal transduction and regulation of the activity of 
membrane proteins [4,5]. Several classes of proteins involved in signal 
transduction mechanisms, have been reported to be associated with lipid 
rafts in cancer cells. Among the proteins known to be localized in lipid 
rafts there is the EGFR [6]. EGFR is a tyrosine kinase mitogenic 
receptor whose function has been implicated in many biological 
processes. Several ligands, including EGF bind and activate the EGF 
receptors [7]. Upon ligand binding, EGFR stimulates signaling pathways 
involved in cell growth, survival, and migration. The EGFR signaling 
has multiple pathways, including the Ras/Raf/MAP-kinase and the 
PI3K/Akt [8,9]. These intracellular signaling cascades result in 
alterations of gene expression, which determines the biological response 
to receptor activation. 
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Specific dietary fatty acids, such as n-3 PUFAs, have been 
suggested to play a key role in the normal development and function of 
the organism.  
Epidemiological studies have suggested that an increased n-3 
PUFA intake might be associated with a reduced breast cancer incidence 
in humans [10,11].  
A number of mechanisms have been proposed for the anticancer 
actions of n-3 PUFAs, DHA and EPA in particular, including inhibition 
of cell proliferation, enhancement of apoptosis, as well as inhibition of 
angiogenesis and metastasis, and cancer differentiation [12-15]. In 
addition, it has also been suggested that these FAs might change the 
localization and function of raft-associated signaling proteins by 
inducing changes in physical properties [16]. DHA, a 22 carbon n-3 FA 
with six cis double bonds, is the longest and most highly unsaturated FA 
founds in most membranes. DHA, due to its high degree of unsaturation, 
has poor affinity and it is sterically incompatible with Chol. Studies 
conducted in various cell types have shown that treatment with DHA can 
alter the structure of lipid rafts as well as the signaling pathways that is 
known to occur within rafts [17-19]. Wong et al., have demonstrated that 
Toll-like receptors, TLR2 and TLR4, signaling pathways and target gene 
expression are modulated by PUFAs. In particular, their results 
demonstrate that DHA inhibits saturated fatty acid-induced dimerization 
and recruitment of TLR4 to lipid rafts, which is the initial step of TLR4 
signaling pathways, suggesting a possibility that n-3 PUFAs inhibit the 
formation of lipid rafts by altering the fatty acid composition of polar 
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lipids that are required to be acylated with saturated fatty acid for the 
formation of liquid-ordered lipid rafts [17].  
 
The EGFR localization in lipid rafts [20,21] is believed to be 
crucial for downstream receptor signaling controlling proliferation and 
apoptosis, which in turn could be altered by n-3 PUFA incorporation. 
Many experimental data have showed in several cell types that 
administration of n-3 PUFAs, in particular DHA, can exclude EGFR 
proteins from lipid raft, suppressing the activation of several downstream 
pathways, including Erk1/2 and Fatty Acid Synthase (FASN) protein 
[22-26]. 
Based on these studies, it has been proposed that lipid raft 
modification can change the localization of raft-associated proteins, 
which could lead to cell death. Therefore, we hypothesized that DHA 
can inhibit breast cancer cell proliferation by altering the localization and 
the signaling pathways of EGFR. In the present work, we have examined 
the effect of DHA administration on DRM microdomains, isolated from 
MDA-MB-231 breast cancer cells by ultracentrifugation, with particular 
interest on EGFR protein localization and its downstream signaling.  
 
7.2 Material and methods 
 
Materials 
DHA (cis-4,7,10,13,16,19-docosahexaenoic acid sodium salt) was 
purchased from Sigma-Aldrich (St Louis, MO, USA). In order to prevent 
oxidation, DHA was dissolved in absolute ethanol, stocked under 
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nitrogen, and stored at −80°C. Epidermal Growth Factor (EGF) was 
purchased from Sigma-Aldrich (St Louis, MO, USA).  
The rabbit polyclonal anti-flotillin-1, the mouse monoclonal anti-
clathrin heavy chain (HC), the rabbit polyclonal anti-EGFR (1005), the 
mouse monoclonal anti-pan Ras (F132),  the rabbit polyclonal anti-p-
Erk1/2 (Thr 202/Tyr 204) and the rabbit polyclonal anti-Erk1/2 
antibodies were purchased from Santa Cruz Biotechnology Inc. (CA, 
USA). The sheep anti-Akt and the mouse monoclonal anti-Akt pS473 
were purchased from Rockland Immunochemicals Inc. (Gilbertsville, 
PA, USA). The monoclonal anti-β-actin (AC-40) antibody was 
purchased from Sigma-Aldrich (St Louis, MO, USA). Bound primary 
antibodies were visualized by the proper secondary horseradish 
peroxidase (HRP)-linked antibodies (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA) and immunoreactivity was assessed by 
chemiluminescence (ECL, PerkinElmer,USA). 
 
Cell Lines and Culture Conditions 
See Chapter 4, section Materials and methods, for a detailed 
description of human breast cancer cells MDA-MB-231. 
During treatments the MDA-MB-231 cell line was seeded 
1.5x10
4
 cells/cm
2
 for 48h. After this period, fresh medium for treatments 
(DMEM + 10% FBS) containing DHA (200µM) was added, and the 
cells were further incubated for 72h without medium replacement. 
Experiments include control cells, which were not exposed to any 
exogenous fatty acids but incubated in the same conditions with the 
same ethanol concentration of treated cells.  
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Cells were then stimulated with EGF. In particular, cells treated 
or not with DHA were cultured in medium for treatments supplemented 
with 10nM EGF and incubated at 37°C for 10min of stimulation. 
Experiments include not stimulated cells, which were not exposed to 
EGF but incubated in the same conditions with fresh medium for 
treatments. 
 
DRMs Isolation  
See Chapter 4, section Materials and methods, for a detailed 
description of DRM isolation from MDA-MB-231 cells. 
 
WB analysis for EGFR, pan-Ras, Erk1/2, p-Erk1/2, Akt, p-Akt 
Control and DHA-treated cell lysates (PNS) were analyzed by 
WB with anti-Erk1/2, anti-p-Erk1/2, anti-Akt and p-Akt antibodies. 
While control and DHA-treated DRMs (fraction 5) were analyzed by 
WB with anti-EGFR and anti-pan-Ras. All samples, 100μg protein/lane 
of total cellular protein, were separated by 10% SDS-PAGE. The 
proteins were then transferred onto a PVDF membrane with Bio-rad 
Transfer Blot Apparatus at 150mA overnight at 4°C in a transfer buffer 
(25mM TrisHCl, 190mM glicine, 20% methanol and 0.05% SDS). 
Following transfer, the samples were analyzed by WB with anti-EGFR 
(1:200), anti-pan-Ras (1:200), anti-Erk1/2 (1:200), anti-p-Erk1/2 (1:200), 
anti-Akt and p-Akt (1:1000) antibodies. The PVDF membranes were 
blocked in blocking buffer to prevent non-specific binding to the 
antibodies. In particular, the membranes were blocked in blocking buffer 
3% dried non-fat milk in Tris-buffered saline (T-TBS: 10mM Tris/HCl, 
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pH 7.5, 150mM NaCl, 0.1% (v/v) Tween®20), for detection EGFR, and 
5% dried non-fat milk in T-TBS, for detection Erk1/2 and p-Erk1/2, Akt, 
p-Akt and pan-Ras at room temperature for 1h. Subsequently, the 
membranes were incubated with an appropriate primary antibody in 
blocking buffer  overnight at 4°C.  
The blots were washed 6 times (5 minutes each) with T-TBS at 
room temperature, and then incubated with the proper secondary 
antibody in blocking buffer at room temperature for 1 h. Finally, after 6 
washes with T-TBS, the specific antibody signals were visualized by 
using the ECL-PLUS (Perkin Elmer, USA), followed by 
autoradiography. The relative intensities of band signals were 
determined by digital scanning densitometry and β-actin, or flotillin-1, 
were used to normalize the results to protein content. 
 
Statistical analysis 
The data are presented as mean ± SD (or SE). Student’s t-test was 
used for comparisons between treated and control cells and the level of 
statistical significance was set at */§p< 0.05 and **p< 0.01.  
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7.3 Results 
 
Previously we observed that n-3 PUFAs are inserted with 
different yield in cell membrane microdomains and are able to alter FA 
composition without decreasing the total percentage of SFA that 
characterize these structures. Moreover, DHA decreased the content of 
Chol and SM in DRM microdomains. Thus, we have hypothesized that 
the alteration of microdomains lipid composition might determine the 
displacement of protein, such as EGFR, from DRMs in n-3 PUFA-
treated cells, with alteration of signal transduction. For these reasons, we 
examined whether DHA redistributes DRM-associated proteins, 
including Ras and EGFR.  
As shows WB in Figure 1A, when DRM preparations from cell 
cultures supplemented with DHA were assessed, the level of EGFR 
protein in DRM fraction was reduced compared to the same fraction of 
untreated cells. Moreover, DHA induces a reduction of EGFR content in 
DRM enriched fraction. A semi-quantitative analysis (Figure 1B) 
showed that the EGFR levels was decreased of 53.65 ± 17.6% in DHA-
treated compared to the control cells (mean ± SEM; n = 3; *p< 0.05). 
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Figure 1. DHA reduces EGFR levels in DRMs. 
Cells were treated with or without DHA (200μM). Some DHA-treated cells were incubated 
with EGF (10nM) before harvest. Following isolation the PNS was fractionated into 11 
distinct fractions by ultracentrifugation. Fractions 5 were collected and analyzed by WB 
using the indicated antibodies (A). Each immunoblot is representative of at least 3 
independent experiments. Flotilli-1 was used to normalized results. (B) Histogram of 
EGFR content in DRMs. Data (mean ± SEM; n=3) are represented as % of control. 
Asterisks indicate significant differences between treated and control cells (*p<0.05). 
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Lateral organization of EGFR within the plasma membrane is 
directly linked to receptor function. In particular, the ability of EGFR to 
activate downstream pathways is correlated to its localization in lipid raft 
domains of the plasma membrane [20,21,27] probably due to co-
localization with downstream mediators within lipid rafts. Previous 
reports have shown that n-3 PUFAs can alter the localization of EGFR 
within the plasma membrane of lung and colon cells [23,24].  
Therefore, we have examined whether DHA can redistributes 
DRM-associated EGFR in MDA-MB-231 cells. As shows WB analysis 
reported in Figure 2A, the low-density fractions (fractions 5 and 6) from 
each treatment were enriched in flotillin-1, which served as lipid raft 
markers, and depleted of clathrin HC, which is excluded from lipid rafts, 
indicating that these fractions were enriched in lipid rafts. When we 
fractionated cells with TX-100 at 4°C, we found that EGFR was present 
in DRM enriched fractions of untreated cells. However, in DHA-treated 
cells EGFR protein was not found predominately in the DRM fractions 
as the lipid raft marker protein flotillin-1 (Figure 2A). In particular, as 
shown in the histogram in Figure 2B, we have observed a reduction of 
EGFR levels in DRM fractions and an increase of EGFR levels in 
detergent soluble membrane (DSM) fractions, indicating a lateral 
reorganization of EGFR across the plasma membrane.  
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Figure 2. Lateral organization of EGFR.  
Cells were treated with or without DHA (200μM). After 72h cells were incubated with or 
without EGF (10nM). Following isolation the PNS was fractionated into 11 distinct 
fractions by ultracentrifugation. (A) Fractions were collected and an equal amount of 
proteins from each fraction was analyzed by WB using antibodies against EGFR, flotillin-
1, and clathrin HC. (B) Quantification of band intensity was performed, and data are 
presented as the relative amount of EGFR in each fraction, with the sum of each fraction 
equaling 100. DRM detergent resistant membrane; DSM detergent soluble membrane. 
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Upon ligand binding, EGFR stimulates signaling pathways 
involved in cell growth, survival, and migration.  
The main signaling pathways activated by EGFR receptors are 
mediated by PI3K/Akt, MAP-kinase and STAT3 [28]. We have decided 
to study the alteration of EGFR-Ras-MAPK and PI3K/Akt pathways. To 
understand the mechanism by which DHA suppresses EGFR signal 
transduction, we assessed the individual components of the EGFR 
signaling axis. In particular, we first determined the effect of DHA on 
localization of Ras within the plasma membrane. Ras, a lipidated proto-
oncogene product, is expressed in three distinct isoforms, H-Ras, N-Ras 
and K-Ras. While K-Ras is exclusively located in the bulk membrane, 
H-Ras is enriched in lipid rafts [29]. The localization of Ras within the 
plasma membrane, the main signaling platform of Ras, and its 
subsequent binding to GTP are required for activation and downstream 
signaling.  
Previous observations reported that DHA can decrease membrane 
association of Ras and concomitantly reduce Ras-dependent signaling, 
cell proliferation, and tumor incidence in transformed mouse 
colonocytes and colonic epithelium from carcinogen-injected rats 
[30,31]. 
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Figure 3. Lateral organization of Ras.  
MDA-MB-231 cells were untreated or treated with  DHA (200µM). After 72h cells were 
incubated with or without EGF (10nM), and the PNS was isolated. Following isolation 
PNS was fractionated into 11 distinct fractions by ultracentrifugation. Fractions were 
collected and an equal amount of proteins from each fraction was analyzed by WB using 
antibodies against Ras, flotillin-1, and clathrin HC.  
 
We hypothesized that DHA may influence Ras membrane 
localization by modifying membrane lipid composition. We evaluated 
the effect of DHA treatment on Ras protein to evaluate as DHA can 
inhibit EGF-induced Ras activation. Our data showed that the 
localization of Ras protein appears to be influenced by DHA treatment 
(Figure 3). In particular, the EGF-stimulation not determine a significant 
change in Ras content within DRMs.  
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However, upon ligand binding, EGFR appear to recruit the Ras 
protein within the plasma membrane. Moreover, after DHA treatment 
most of the protein does not remain in the DRM enriched fractions. A 
semi-quantitative analysis allowed to calculate Ras levels in DRMs. In 
particular, Figure 4 shows a reduction of Ras content in DRMs of 74.1 ± 
7.4% (mean ± SEM; n = 3) after DHA treatment compared to the 
untreated cells (**p< 0.01).   
Also, as reported in Figure 4B, our findings showed that a 
combination of EGF- and DHA treatment determines a reduction of Ras 
content of 82.0 ± 5.1% (mean ± SEM; n = 3) compared to control (**p< 
0.01), and a reduction of 84.4 ± 10.2% (mean ± SEM; n = 3) compared 
to EGF-treated cells (§p< 0.05). These results indicate that, in addition to 
the altered localization of EGFR, also Ras protein appears to be affected 
by DHA treatment.  
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Figure 4. DHA reduces Ras levels in DRMs. Cells were treated with or without DHA 
(200μM). Some DHA-treated cells were incubated with EGF (10nM) before harvest. PNS 
were fractionated and fractions 5 were collected and analyzed by WB using antibodies 
against Ras and flotillin-1 (A). Flotillin-1 was used to normalized results. (B) Data (mean ± 
SEM; n=3) are represented as % of control (**p<0.01; §p<0.05). Each immunoblot is 
representative of at least 3 independent experiments. 
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Some studies link the tumour-suppressive action of n-3 PUFA 
with the MAP-kinase pathway and the inactivation of its components 
with the induction of apoptosis [32] suggesting that there may be tissue 
or cancer specific mechanisms of n-3 PUFA action. In particular, as 
regards Extracellular signal-regulated Kinase 1/2 (Erk1/2), some studies 
showed that n-3 PUFAs promote apoptosis in cancer cells by reducing 
the levels of p-Erk1/2 [33,34]. Moreover, in recent years, a second 
pathway downstream of receptor tyrosine kinases (RTKs), sometimes 
via Ras, that involves PI3K and AKT has come onto the scene. AKT, 
also known as protein kinase B, is a serine/threonine kinase and  
promotes cell survival and growth by potentiating NF-κB activity and 
the mammalian target of rapamycin (mTOR) [35]. Because the PI3K/Akt 
signalling pathway mediates cell proliferation, survival and motility, Akt 
is implicated in the oncogenesis of many cancers.  
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Figure 5. DHA reduces activation of Erk1/2.  
Cells were treated with or without DHA (200μM). Some DHA-treated cells were incubated 
with  EGF (10nM) before harvest. PNS were collected and processed by WB using the 
indicated antibodies (A). Each immunoblot is representative of at least 3 independent 
experiments. (B) Quantification of band volume was performed and data are presented as 
mean ± SEM; n=3. Data are expressed as the ratio of the p-Erk1/2 to total Ekr1/2 protein 
and normalized to control (mean ± SEM; n=3). Asterisks indicate significant differences 
between DHA- and EGF-treated compared to CTR cells (**p<0.01; *p<0.05), and between 
DHA/EGF- and EGF-treated cells (§p<0.05). 
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Since EGFR phosphorylation is characteristically associated with 
activation of downstream signaling, we further probed cell lysates (PNS) 
for phosphorylation of EGFR downstream effector proteins, including 
Erk1/2 and Akt. As shown in Figure 5A, Erk1/2 was phosphorylated 
after incubation with EGF (10nM) for 10min, while the incubation with 
DHA decreased the phosphorylation of Erk1/2 both in EGF-treated and 
untreated cells. A semi-quantitative analysis allowed to calculate the 
variation of p-Erk1/2, see histogram reported in Figure 5B. In particular, 
the EGF-stimulation increases the phosphorylation of Erk1/2 of 1.5 fold 
compared to untreated cells (*p<0.05). p-Erk1/2 showed to be sensitive 
to the DHA treatment, its levels markedly decreased. DHA treatment 
resulted in a ~90% reduction in the activation of Erk1/2 in DHA treated 
compared to the control cells. Moreover, DHA determines a reduction of 
p-Erk1/2 about of 60% compared to the EGF-treated cells. 
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Figure 5. DHA reduces activation of Akt.  
Cells were treated with or without DHA (200μM). Some DHA-treated cells were incubated 
with EGF (10nM) before harvest. PNS were collected and processed by WB (A) using the 
indicated antibodies. Each immunoblot is representative of at least 3 independent 
experiments. (B) Data (mean ± SEM; n=3) are represented as % of control (*/§p<0.05) and 
β-actin was used to normalized results  
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PI3K is implicated in protecting cells against apoptosis [36], 
moreover, the Akt signaling pathway plays a crucial role in cancer 
progression. It has been reported that inactivation of PI3K/Akt signaling 
by DHA enhances cell death, although the mechanisms involved in 
DHA-induced Akt inactivation have not been well addressed [37]. For 
this reason, we tested alterations of the levels of phosphorylation of the 
downstream target of PI3 kinase, Akt. As shown Figure 5A, incubation 
with EGF (10nM) for 10min determines an increased of the 
phosphorylation of Akt, while DHA-incubation decreases p-Akt levels. 
In particular, a semi-quantitative analysis (Figure 5B) allowed to 
observe a reduction of p-Akt levels of 52.2 ± 15.5% in DHA-treated 
cells compared to the untreated cells (mean ± SEM; n = 3; *p< 0.05). 
Our findings showed that the EGF-stimulation increases the 
phosphorylation of Akt of 3 fold compared to untreated cells (*p< 0.05), 
while  the combination of DHA/EGF treatment determines a reduction of 
p-Akt levels of 57.9 ± 18.8% compared to the EGF-treated cells 
(mean ± SEM; n = 3; §p< 0.05). 
Take together these data indicate that the DHA can redistribute 
lipid raft-associated proteins, such as EGFR, and its downstream 
signaling, in particular EGFR-Ras-Erk and PI3K/Akt pathways. 
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7.4 Discussion 
 
Epidemiological studies support the hypothesis that an increased 
n-3 PUFA intake can inhibit the formation and progression of cancers 
[38-39]. However, although it is acknowledged that n-3 PUFAs may act 
on the cancer, the specific mechanisms by these FAs may exert their 
modulatory effects on cancer are not fully understood. n-3 PUFAs 
appear to be involved in multiple mechanisms that connect the cell 
membrane, the cytosol, and the nucleus.  
This study was prompted by the observation on previously results 
obtained in our laboratory. We observed that DHA may change the 
biophysical properties of DRM microdomains by decreasing the content 
of Chol and SM, due to its incorporation in membrane PLs [19]. Thus, 
we suggest that the alteration of microdomains lipids composition might 
determine the displacement of proteins, such as EGFR, from rafts in n-3 
PUFA treated cells with alteration of signal transduction and induction 
of apoptosis. 
Membrane microdomains, known as lipid rafts, are heterogeneous 
microdomains enriched in Chol, SM and saturated PLs. They are highly 
dynamic and may rapidly assemble and disassemble, leading to a 
dynamic segregation of proteins. They can include or exclude a variety 
of proteins, such as receptor activities and therefore signal transduction 
[4]. Among the proteins known to be localized in lipid rafts there is the 
EGFR [6]. EGFR is a 170 kDa transmembrane receptor tyrosine kinase, 
which is frequently over-expressed in many human tumours such as lung 
and breast cancers [40]. 
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 We have chosen MDA-MB-231 cells because  they express high 
levels of the EGFR [39] and are a good model to study EGFR raft 
modulation by n-3 PUFAs. Upon ligand binding, EGFR recruits 
downstream signalling proteins, triggering signal cascades along a 
number of pathways that eventually lead to cell growth, migration and 
apoptosis resistance. Key to the ability of EGFR to activate downstream 
pathways is its localization in lipid raft domains of the plasma membrane 
[20,22,24,42]. Our results shown that DHA is able to reduce EGFR 
content in DRM enriched fractions compared to the same fractions of 
untreated cells. We have hypothesized that the reduction of EGFR 
content in DRM microdomains by DHA might be the consequences of 
membrane microdomains alterations induced by FA. 
Our recent studies [13,19] suggest that n-3 PUFA induce 
modifications of membrane structure and function of breast cancer cells, 
thereby increasing the degree of unsaturation. In particular, we have 
observed that EPA and DHA were incorporated in membrane 
microdomains with different specificity for PLs. Moreover, DHA 
determines a reduction of SM (about 40%) and Chol (about 70%) 
content in membrane microdomains.  
Since lipid rafts are predominantly enriched in saturated fatty 
acids and Chol, the incorporation of DHA determines a structural 
reorganization of microdomains rafts due to steric incompatibility 
between Chol and DHA [16,43]. In fact, the poor affinity of DHA for 
Chol alter the size, stability and distribution of membrane microdomains.  
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Thus, the reorganization of membrane microdomains could be the 
mechanism by which DHA can exclude EGFR proteins from membrane 
microdomains. Lateral organization of EGFR within the plasma 
membrane is directly linked to receptor function. Coskun et al., have 
recently showed that the membrane lipid environment can modulate the 
localization and function of EGFR. In particular, they have observed that 
in a three-component lipid mixture consisting of unsaturated PC, SM an 
Chol, not occurs the EGFR autophosphorylation in absence of EGF, 
though allowing the ligand-mediated receptor dimerization and its 
activation. Moreover, when GM3 was added to the ternary lipid mixture 
EGFR autophosphorylation was inhibited without affecting ligand 
binding. Their result shows that lipids can function in the allosteric 
regulation of EGFR function [44]. Analyzing DRM and DSM fractions 
we observed a lateral reorganization of EGFR within the plasmatic 
membrane after DHA incubation. In particular, we observed a reduction 
of EGFR level in DRM fractions, and an increase of EGFR level in DSM 
fractions (Fig. 2) compared to the untreated cells.  
Therefore, the DHA-induced shift of EGFR localization within 
the plasma membrane alters the ability of the receptor to dimerize and 
transphosphorylate Our finding is in favorable agreement with the model 
proposed by Turk et al., according to which receptor modulation by FAs 
is mediated by the membrane [24].  
The main signaling pathways activated by EGFR receptors are 
mediated by PI3K/Akt, MAP-kinase and STAT3 [28]. To understand the 
mechanism by which DHA suppresses EGFR signal transduction, we 
assessed the individual components of the EGFR signaling axis.  
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Ras is expressed in three distinct isoforms, H-Ras (enriched in 
lipid rafts), N-Ras and K-Ras (exclusively located in the bulk 
membrane) [29]. The localization of Ras within the plasma membrane is 
required for activation and downstream signaling. Previous observations 
reported that DHA can decrease membrane association of Ras and 
concomitantly reduce Ras-dependent signalling and cell cell 
proliferation, and tumor incidence in transformed mouse colonocytes 
and colonic epithelium from carcinogen-injected rats [39].  
Our data showed that the localization of Ras protein appears to be 
influenced by DHA treatment and EGF stimulation (Fig. 3). In 
particular, after EGF-stimulation we observed an increases of Ras level 
within plasmatic membrane suggesting the recruitment of this protein for 
activate the EGFR-Ras-MAPK pathway. Moreover, after DHA treatment 
most of the protein not appear to be associate within plasmatic 
membrane, especially within membrane microdomains (Fig. 4). 
Moreover, DHA is able to suppress the EGF-stimulated activation of 
Ras. Recent findings have demonstrated a partitioning of Ras into lipid 
rafts and caveolae, and effects of n-3 PUFAs on Ras membrane 
compartmentalization have been examined in vivo and in vitro models 
[39].  
The Chapkin laboratory showed that dietary n-3 PUFAs are 
capable of displacing acylated proteins from lipid raft both in vivo and in 
vitro models. Feeding mice a diet enriched in n-3 PUFA and treating 
immortalized YAMC cells with DHA decreased the localization of H-
Ras in lipid raft domains, suggesting that changes in membrane lipid 
composition directly influence the intracellular trafficking and 
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subcellular localization of lipidated proteins [45,46]. Our results are in 
agreement with these observation. In particular, our results indicate that, 
in addition to the altered localization of EGFR, also Ras protein appears 
to be affected by DHA treatment, due to its incorporation in membrane 
microdomain PLs, which structural reorganization of microdomains. In 
addition to Ras down-regulation, we found that in breast cancer cells 
DHA is able to cause a decrease in the phosphorylation state of  Erk1/2. 
Our results indicate that DHA is probably decreasing cell proliferation in 
part, by down regulating Ras/Erk signaling. Many cancer cells are 
associated with aberrant PI3K/Akt signaling that up regulates cell 
proliferation mechanisms and suppresses apoptosis [47,48]. Our results 
showed that DHA interferes with Akt phosphorylation on S473 in MDA-
MB-231 breast cancer cells. In our previously work [13] we have 
observed that n-3 PUFA were incorporated in breast cancer cell 
membrane with different specificity for the PLs moiety. The enrichment 
was significant, especially in PE, PI and PC. Moreover, in agreement 
with the results obtained by Gu et al., [49] we supposed that the 
incorporation of DHA into cell membrane could modify PL content and 
consequently the membrane protein localization, including Akt.  
PI3K phosphorylates PIP2 to PIP3 that stimulates the activity of 
Akt. PIPs (PIP2 and 3) are PLs composed of a glycerol backbone with 
FAs at the sn-1 and sn-2 position and inositol at the sn-3 position. When 
Akt is recruited to the plasma membrane through direct contact with 
PIP3, it is phosphorylated and activated. Akt can phosphorylate proteins, 
such as pro-caspase-9 and BAD, and is involved in the regulation of 
apoptosis, gene expression, cell proliferation migration and angiogenesis 
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[39]. Gu et al., have showed that DHA can replace the FA at the sn-2 
position of the glycerol backbone, thereby changing the species of PLs. 
In particular, DHA alters PIP3 and, consequently, the activation of Akt 
(S473) protein, suppressing AKT signaling pathway and prostate tumor 
growth [49]. 
 
7.5 Conclusion 
 
Based on the work presented here, DHA play a key role in 
regulating signal transduction. In particular, we demonstrated that DHA 
can exclude key proteins, such as EGFR and Ras, from membrane 
microdomains, thus modifying their downstream signaling, such as Erk 
and Akt.  
In conclusion, the treatment with DHA determines a reduction of 
cell proliferation by inhibiting of EGFR activity, thus suggesting that 
these effects might be the consequences of the alteration in membrane 
microdomains induced by this FA. 
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